–؉ºª–ç, ‰«“c—‹M, –쓇—YŽj, Å‘ŠW•ã, ´…Ž•F, ’†“c¹’j, ŽŒÒ’¼Ž÷
’E—Ž–ŒŒ^ˆ««‹¹–Œ’†”çŽî‚̈ê—á
‘æ180‰ñ‰ªŽRŠO‰È‰ïŠw‰ï(‘q•~)(2017.12.2)
‰ª“c•q³, ‰Í‡º¹, •õ“cC–¾, ‰ª–{—R—CŽq, ‰Y‰ª–¢‰›, ã–쑾•ã, “nç²—Tô, ŒE“cŽõŽq, “Œ“c³—z, ‰ª•Û•v, ’ß“c~, m‰È‘yŽ¡, X’J‘ì–ç, “¡Œ´—R‹K, ã–ì•x—Y
ŠÌƒAƒjƒTƒLƒXÇ‚Ì1—á
‘æ79‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï(“Œ‹ž)(2017.11.23)
•Ä—º—S, •Ÿ‰®”ü“ÞŽq, ›–ì–LŽq, ¬—Ñ]—˜, ¬—Ñ”Ž‹v, ¼‘ºLŒ’, ˆÉâXŒ÷, HŽR—², ŽŒÒ’¼Ž÷, X’J‘ì–ç, ’蕽‹g“s
PEL-like lymphoma‚Ì‘œ‚ð’æ‚µ‚½MTXŠÖ˜AƒŠƒ“ƒp‘B«Ž¾Š³‚Ì1—á
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2017.11.19)
¬—Ñ”Ž‹v, ›–ì–LŽq, •Ä—º—S, ¬—Ñ]—˜, •Ÿ‰®”ü“ÞŽq, ŽŒÒ’¼Ž÷, X’J‘ì–ç
ŒÄ‹zŠí×–Ef‚É‚¨‚¯‚é^‹ÛŒŸo‚ÌH•v
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2017.11.19)
’·“ˆ^‹I, ‚‹´—Ç•ã, •½ì‹v, –Ø‘º“¹•v, “n•Ó‚Ý‚©, X’J‘ì–ç
“û‘B×–Ef‚ÌŒ»ó‚ÆV’mŒ© “û‘B޾г‚ɑ΂·‚é×–Ef‚Ì–ðŠ„‚Ì•Ï‰»
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2017.11.18)
™]’mŽ¡, ²“¡‰iˆê, ‹{‰º õ, ŽOã–FŠì, ŽRŒû —Ï, â’J‹MŽi, ¬’Ë—SŽi, X’J—éŽq, —é–Ø‰hŽ¡, Š_Œ©˜aG, X’J‘ì–ç
u‚»‚ꂼ‚ê‚ÌŠàv“«Šà‚ɑ΂·‚鎡—Ãí—ª@“û‘B Šà”÷¬ŠÂ‹«‚É‚¨‚¯‚éƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu“ûŠà‚̖Ɖu‰ž“š
‘æ55‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(‰¡•l)(2017.10.21)
²ŠÑŽj–¾
“ª•”Žîá‡
‘æ222‰ñ‰ªŽRŠO‰È•a—Œ¤‹†‰ï(‰ªŽR)(2017.10.13)
âV“¡Â, ‰HŠÔ—[‹IŽq, —é–Ø‘ˆê˜Y, ¼–{ŒjŽq, ¼–{—Ç, ™Œ´–í, ²–ì—ÍÆ, Γc„, ‘º“cW, ’†ˆä—Sˆê˜Y, ‘º“c‘ì–ç, ‰–“c[, ’†‘º—²•¶, X’J‘ì–ç, g—Ñ~ˆê, ‰º‰®_ˆê˜Y
”DP’†‚É‹}‘¬‘‘債‚½“û‚ª‚ñ‚ɑ΂µ‚ÄŽèpE‰»Šw—Ö@‚ðŽ{s‚µ‚½1—á
‘æ70‰ñ’†‘Žl‘ŽY‰È•wl‰ÈŠw‰ï(L“‡)(2017.9.24)
ŽŒÒ’¼Ž÷
Z«¬—tŠà‚Ì•a—
‘æ1‰ñ“Þ—Ç‹¹•”i”xE“ûj޾гŒ¤‹†‰ï(“Þ—Ç)(2017.9.23)
ŽŒÒ’¼Ž÷
WHO•ª—Þ‚ðŠÜ‚ß‚½Z«¬—tŠà‚Ìf’f‚Æ•ªŽq•a—Šw“I“Á’¥‚É‚æ‚é—\Œã“™‚Ƃ̊֘A
‘æ32‰ñ_“Þì“û‘BŽ¾Š³Ç—áŒŸ“¢‰ï(‰¡•l)(2017.9.16)
‰HŠÔ—[‹IŽq, ²–ì—ÍÆ, ’ª‘½ŽŠ‰›, ‘º“c‘ì–ç, ‰–“c [, ‰º‰®_ˆê˜Y, X’J‘ì–ç, ’†‘º—²•¶
is—‘‘ƒ–¾×–EŠà‚Ì×–EŽüŠú‚Æ—\Œã‚ɂ‚¢‚Ă̌Ÿ“¢
‘æ59‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(ŒF–{)(2017.7.27)
g—Ñ~ˆê, ¬’r—ǘa, ‘¾“c—T‰î, ŽR‰º“N³, âV“¡˜i, ŠÝ–ì‰l”ü, ŽŒÒ’¼Ž÷, X’J‘ì–ç
HedgehogƒVƒOƒiƒ‹“`’BŒo˜H‚ð‰î‚µ‚½“ûŠàвזE§Œä‹@\
‘æ26‰ñ“ûŠàŠî‘bŒ¤‹†‰ï(ŒQ”n)(2017.7.23)
•Ÿ‰®”ü“ÞŽq, ¬—Ñ”Ž‹v, X’J‘ì–ç, ŽŒÒ’¼Ž÷
ŒÄ‹zŠí×–Ef•W–{컂Ɋւ·‚éŠî‘b“IŒŸ“¢
‘æ32‰ñ“ú–{—Õ°×–EŠw‰ï’†‘Žl‘˜A‡‰ï‘‰ïEŠwpW‰ï(‰ªŽR)(2017.7.23)
•Ä—º—S, •Ÿ‰®”ü“ÞŽq, ›–ì–LŽq, ¬—Ñ]—˜, ¬—Ñ”Ž‹v, ¼‘ºLŒ’, ˆÉâX Œ÷, HŽR—², ’蕽‹g“s, X’J‘ì–ç, ŽŒÒ’¼Ž÷
×–EfŒŸ‘Ì‚ð—p‚¢‚½–ƉuõF ×–Ef‚¨‚æ‚уZƒ‹ƒuƒƒbƒNŒŸ‘Ì‚ð—p‚¢‚½–ƉuõF‚ɂ‚¢‚Ä
‘æ32‰ñ“ú–{—Õ°×–EŠw‰ï’†‘Žl‘˜A‡‰ï‘‰ïEŠwpW‰ï(‰ªŽR)(2017.7.22)
“¡ˆä´, ’Å–ØŽ —Y, X’J‘ì–ç
“ûŠÇ“à“û“ªŽî‚ÆDCIS‚ª¬Ý‚µAZŠà‚Ƃ̊ӕʂɋꗶ‚µ‚½1—á
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
–쑺’·‹v, ŽOㄎi, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ¬‘qˆêŒb, ŽR–{³—˜, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŽR‰º“N³, ŠÖ^—, ‘y“c–ƒˆß, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
•ÂŒo󋵂ðl—¶‚µ‚½ƒvƒƒQƒXƒeƒƒ“ƒŒƒZƒvƒ^[‚Ìd—v«
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
ŽŒÒ’¼Ž÷, g—Ñ~ˆê, ŽRŒû—Ï, X’J‘ì–ç
“ûŠà‚É‚¨‚¯‚éCD1d”Œ»‚Í”÷¬“û“ªóŒ`‘ÔA–¬ŠÇNPAŽîᇌa‚Æ—LˆÓ‚È•‰‚Ì‘ŠŠÖŠÖŒW‚ðŽ¦‚·
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
ŽR‰º“N³, ¬‘qˆêŒb, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ŽR–{³—˜, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŠÖ^—, ‘y“c–ƒˆß, –쑺’·‹v, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“à•ª”å—Ö@ŠùŽ¡—ÂÌÄ”“ûŠàÇ—á‚É‚¨‚¯‚é Medroxypogesterone acetate Žg—p‚ÌŒŸ“¢
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
’†“‡Œì—Y, •“cŒ³”Ž, –Ø‘º“¹•v, •½ì‹v, ŠÃ—˜³˜a, ˆÉ“¡³—T, [’¬‰À¢Žq, X’J‘ì–ç
‚Ù‚Ú“¯ŽžŠú‚Éf’f‚³‚ꂽ‰»¶Šà2—á(œE“»¶‚𔺂¤ŠàA–a×–EŠà)‚ÌŒŸ“¢
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
•½ì‹v, ŠÃ—˜³˜a, ˆÉ“¡³—T, [’¬‰À¢Žq, ²”ŒŸl, •“c–r, –Ø‘º“¹•v, •“cŒ³”Ž, ’†“‡Œì—Y, ’·“ˆ^‹I, X’J‘ì–ç
“û–[ØœŒã‚̈ꎟ“ñŠúÄŒš‚ð—\’肵‚½‚ªAp’†”»’f‚Å’†Ž~‚ƂȂÁ‚½Ç—á‚ÌŒŸ“¢
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
ŽOㄎi, ¬‘qˆêŒb, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ŽR–{³—˜, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŽR‰º“N³, –쑺’·‹v, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç, ŠÖ^—, ‘y“c–ƒˆß
”ñZ«“ûŠÇŠà—l‚ÌŒ`‘Ô‚ðŽ¦‚µ‚½ˆ««‘B‹Øã”çŽî‚Ì1—á
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
X’J‘ì–ç
“ûŠà‚É‚¨‚¯‚étumor infiltrating lymphocyteŒŸõ‚ÌŒ»ó
‘æ25‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•Ÿ‰ª)(2017.7.13)
²ŠÑŽj–¾
ŠÌŽîᎂ̈ê—á
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”‘æ123‰ñƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒX(‘q•~)(2017.6.24)
g—Ñ~ˆê, ŠÝ–ì‰l”ü, ¬’r—ǘa, ‘¾“c—T‰î, âV“¡˜i, ŽR‰º“N³, ŽŒÒ’¼Ž÷, X’J‘ì–ç
ƒGƒXƒgƒƒQƒ“Žó—e‘Ì—z«“ûŠà×–E‚É‚¨‚¯‚éŠàвזEŒ`Ž¿‚̧Œä‹@\
‘æ18‰ñƒzƒ‹ƒ‚ƒ“‚ÆŠàŒ¤‹†‰ï(‘O‹´)(2017.6.23)
¬—Ñ]—˜C•Ÿ‰®”ü“ÞŽqC•Ä —º—SC›–ì–LŽqCŽŒÒ’¼Ž÷CX’J‘ì–ç
‘½Ê‚È‘œ‚𔺂Á‚½“ûŠà‚Ì1—á
‘æ58‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‘åã)(2017.5.27)
›–ì–LŽqC•Ÿ‰®”ü“ÞŽqC•Ä —º—SC¬—Ñ]—˜C¬—Ñ”Ž‹vCHŽR —²CŽŒÒ’¼Ž÷CX’J‘ì–ç
’e«üˆÛŽî‚Ì2—á
‘æ58‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‘åã)(2017.5.27)
•Ÿ‰®”ü“ÞŽqCŽŒÒ’¼Ž÷CX’J‘ì–ç
‰»¶Šà‚Ì×–E‘œ
‘æ58‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‘åã)(2017.5.26)
X’J‘ì–ç
“û‘BŽîá‡‚Ì WHO •ª—Þ:‘æ4”ł̊T—v
‘æ58‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‘åã)(2017.5.26)
‘¾“c—T‰î, “c’†Ž_, ¬‘qˆêŒb, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ŽR–{³—˜, âV“¡ ˜i, ¬’r—ǘa, ŽR‰º“N³, –쑺’·‹v, ŽR–{ —T, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
bó‘B–¢•ª‰»Šà×–EŠ”‚ɑ΂·‚éSrc‘jŠQ–ò‚ÌRŽîᇌø‰Ê‹y‚ÑŠàŠ²×–E‚É—^‚¦‚é‰e‹¿
‘æ29“ú–{“à•ª”åŠO‰ÈŠw‰ï¥“ú–{bó‘BŠO‰ÈŠw‰ï(_ŒË)(2017.5.19)
a’J—¢ŠG, ’·À œA, X’J‘ì–ç
‹Øã”ç‚È‚¢‚µŠî’ê×–E‚Ö‚Ì•ª‰»‚ðŽ¦‚·”÷¬Z‚𔺂¤DCIS‚̈ê—á
‘æ106‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2017.4.29)
X’J‘ì–ç, ˆî‹g‹MŠG, ŽŒÒ’¼Ž÷
”ñZ«“ûŠÇŠà‚É‚¨‚¯‚éintegrin ƒ¿vƒÀ6‚Ì”Œ»‚ÉŠÖ‚·‚é–Æ‰u‘gDŠw“IŒŸ“¢
‘æ106‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2017.4.29)
ŽŒÒ’¼Ž÷, ˆî‹g‹MŠG, X’J‘ì–ç
Ž©‘R‘Þk‚ðŽ¦‚µ‚½“ûŠàÇ—á‚ÌLC/MS/MS‚É‚æ‚é’`”’‰ðÍ
‘æ106‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2017.4.29)
‹Ê“c •×,ŽŒÒ’¼Ž÷, ‹{’n’õK ,–ØŒË •à, Œ´ ˆ»‰p, ‰iˆä “Ö, ˆÉ“ŒŽ”\
ƒ}ƒ‹ƒ`ƒpƒ‰ƒƒgƒŠƒbƒNMRI‚ð—p‚¢‚½‘O—§‘B‘S“EpŒã‚ÌØœ’f’[‚Ì—\‘ªˆöŽq‚ÉŠÖ‚·‚錤‹†
‘æ105‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï(ŽŽ™“‡)(2017.4.21)
ŽŒÒ’¼Ž÷
“ûŠàVASH2”Œ»‚̖Ɖu‘gDŠw“IŒŸ“¢
‘æ12‰ñVasohibinŒ¤‹†‰ï(å‘ä)(2017.2.5)
“c’†—¹, –Ø‘º“OŽq, —ÑG–¾, X’J‘ì–ç, “¡–{˜j
¶–j•”‚ÌgFŽîáŽ
‘æ68‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”Šwp‘å‰ï(•ÄŽq)(2016.11.20)
Kurebayashi Junichi, Koike Yoshikazu, Ohta Yusuke, Saitoh Wataru, Yamashita Tetsumasa, Kanomata Naoki, Moriya Takuya
Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 and antiestrogens in estrogen receptor-positive breast cancer cells
The 14th Breast Cancer Frontier Meeting(“Œ‹ž)(2016.11.19)
¬—Ñ”Ž‹vC›–ì–LŽqC•Ä —º—SC ¬—Ñ]—˜C•Ÿ‰®”ü“ÞŽqCŽŒÒ’¼Ž÷, X’J‘ì–ç, ’蕽‹g“s
×–Ef‰æ‘œ‚É‚¨‚¯‚éÅ“_E˜Io‚̉掿‰ü‘P \ ŽB‰e‚©‚ç‰æ‘œ‡¬‚܂ł̎©“®‰»‚ÌŽŽ‚Ý\
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘啪)(2016.11.19)
¬—Ñ”Ž‹vC›–ì–LŽqC•Ä —º—SC¬—Ñ]—˜C•Ÿ‰®”ü“ÞŽqCŽŒÒ’¼Ž÷Cà_èŽüŽŸCX’J‘ì–ç
‹CŠÇŽx‹¾‰º×–Ef‚ª—L—p‚Å‚ ‚Á‚½ƒAƒŒƒ‹ƒM[«‹CŠÇŽx”xƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ(ABPA)‚Ì 1 —á
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘啪)(2016.11.19)
’·“ˆ^‹IC•½ì ‹vC•“cŒ³”ŽC–Ø‘º“¹•vCX’J‘ì–ç
“û‘B‚Ì‹«ŠEˆ««•a•Ï@×–Ef‚Ç‚±‚܂Ŕ—‚ê‚é‚©?@‹«ŠE•a•Ï‚Ì×–EŠw“IŒŸ“¢:FEA ‚¨‚æ‚Ñ Low grade DCIS ‚ð’†S‚É
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘啪)(2016.11.19)
•Ä —º—SC•Ÿ‰®”ü“ÞŽqC›–ì–LŽqCŠâ’m“¹L‹vC¬—Ñ]—˜C¬—Ñ”Ž‹vCècŒ´‘ñ—YC”© žÄC¼‘ºLŒ’CˆÉâX Œ÷CHŽR —²CŽŒÒ’¼Ž÷Cà_èŽüŽŸCX’J‘ì–çC’蕽‹g“s
–ƉuõF‚ƃZƒ‹ƒuƒƒbƒN–@@×–E“]ŽÊ–@‚Ìg‚±‚ê‚Ü‚Åh‚Æg‚±‚ê‚©‚çh\ –Ɖu×–E‰»Šw‚ð’†S‚É\
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘啪)(2016.11.19)
ŽŒÒ’¼Ž÷
“û‘B×–Ef‚É‚¨‚¯‚é–Æ‰uõFE•ªŽq¶•¨Šw“IŽè–@‚̉ž—p
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘啪)(2016.11.19)
X’J‘ì–ç
“û‘B•a—‚ÌŠî–{‚ðŠy‚µ‚Šw‚Ñ‚½‚¢@”ñZ«“ûŠÇŠà‚̃oƒŠƒG[ƒVƒ‡ƒ“
‘æ37‰ñ“ú–{“û‘Bbó‘B’´‰¹”gˆãŠw‰ïŠwpW‰ï(é‹Ê)(2016.10.15)
—é–Ø‘ˆê˜Y, ²–ì—ÍÆ, ¼–{ —Ç, ¼–{ŒjŽq, ‰HŠÔ—[‹IŽq, ™Œ´–í, Γc „, ‘º“c W, ’ª“cŽŠ‰›, ‘º“c‘ì–ç, ’†ˆä—Sˆê˜Y, ’†‘º—²•¶, ‰º‰®_ˆê˜Y, X’J‘ì–ç, ‰–“c[
4~2mm‚Ì”÷¬Z—Þ“à–Œ‘BŠà‚𔺂Á‚½—‘‘ƒŽq‹{“à–ŒÇ«”X–E‚̈ê—á
‘æ69‰ñ’†‘Žl‘ŽY‰È•wl‰ÈŠw‰ï‘‰ï‚È‚ç‚тɊwpu‰‰‰ï(‚¼)(2016.9.25)
ŽŒÒ’¼Ž÷
•a—f’f‚É‚¨‚¯‚éƒoƒCƒIƒ}[ƒJ[
‘æ48‰ñ“ú–{—Õ°•ªŽqŒ`‘ÔŠw‰ï(ŒF–{)(2016.9.24)
X’J‘ì–ç
—‘‘ƒŽîᇕa—‚Ì•ÏX“_
‘æ52‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï(“Œ‹ž)(2016.9.17)
Hiroto Akaike, Junko Minagi, Nobuhiko Nakamura, Takuya Moriya, Kozo Kawasaki.
hCan liver lower edge be palpated? hSimulation-based instruction reduced anxiety
The Association for Medical Education in Europe 2016(Barcelona, Spain)(2016.9.1)
g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ŽR‰º“N³, ¬’r—ǘa, ‘¾“c—T‰î
“ûŠàEbó‘BŠà‚É‚¨‚¯‚éŠàвזE§ŒäƒƒJƒjƒYƒ€‚̉ð–¾
‘æ7‰ñìèˆã‰È‘åŠwŠwpW‰ï(‘q•~)(2016.8.6)
g—Ñ~ˆê, ¬’r—ǘa, ‘¾“c—T‰î, âV“¡˜i, ŽŒÒ’¼Ž÷
ƒwƒbƒWƒzƒbƒOƒVƒOƒiƒ‹“`’B‘jŠQ–òGANT61‹y‚ÑRƒGƒXƒgƒƒQƒ“–ò‚̃zƒ‹ƒ‚ƒ“Š´Žó«“ûŠà×–E‚ɑ΂·‚éRŽîᇌø‰Ê‹y‚ÑŠàŠ²×–E
‘æ25‰ñ“ûŠàŠî‘bŒ¤‹†‰ï(“Þ—Ç)(2016.7.23)
X’J‘ì–ç
•wl‰ÈŠó޾г‚ÌŽ¡—Ã@¬n”X–E«ŠïŒ`Žî‚̈««“]‰»‚ɂ‚¢‚Ä ¬n”X–E«ŠïŒ`Žîˆ««“]‰»‚Ì•a—
‘æ58‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(•ÄŽq)(2016.7.8)
ŽR‰º“N³, g—Ñ~ˆê, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ¬‘qˆêŒb, ŽR–{³—˜, âV“¡ ˜i, ¬’r—ǘa, ‘¾“c—T‰î, –쑺’·‹v, ŽR–{ —T, “c’†Ž_, ŽŒÒ’¼Ž÷, X’J‘ì–ç
isÄ”“ûŠàгŽÒ‚É‚¨‚¯‚鋹…ƒZƒ‹ƒuƒƒbƒN‚Ì•a—Šw“I•]‰¿‚ɂ‚¢‚Ă̌Ÿ“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.18)
¬’r—ǘa, ‘¾“c—T‰î, ŽŒÒ’¼Ž÷, X’J‘ì–ç, g—Ñ~ˆê
ƒwƒbƒWƒzƒbƒOƒVƒOƒiƒ‹“`’B‘jŠQ܂̃gƒŠƒvƒ‹ƒlƒKƒeƒBƒu“ûŠà×–E‚ɑ΂·‚éRŽîᇌø‰Ê‚ÆŠàŠ²×–E§Œäì—p‚ÌŒŸ“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.17)
g—Ñ~ˆê, ¬’r—ǘa, ‘¾“c—T‰î, ŽR‰º“N³, Ö“¡ ˜i, ŽŒÒ’¼Ž÷, X’J‘ì–ç
ƒwƒbƒWƒzƒbƒO“`’B‘jŠQ–òGANT61‚̃zƒ‹ƒ‚ƒ“Š´Žó«“ûŠà×–E‚ɑ΂·‚éRŽîᇌø‰Ê‹y‚ÑŠàŠ²×–E§Œä‚ÉŠÖ‚·‚錤‹†
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.17)
X’J‘ì–ç, ŽŒÒ’¼Ž÷, g—Ñ~ˆê, —é–Ø ‹M
“ûŠà‚̉ŠúZƒƒJƒjƒYƒ€‰ð–¾‚ÉŠÖ‚·‚é–Æ‰u‘gDŠw“IŒŸ“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.17)
–쑺 ’·‹v, ŠÝ–ì‰l”ü, ›Œ´Ž¬D, ¬‘qˆêŒb, ŽR–{³—˜, Ö“¡˜i, ¬’r—ǘa, ‘¾“c—T‰î, ŽR‰º“N³, ŽR–{ —T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“–‰È‚É‚¨‚¯‚é“ûŠàƒŠƒXƒNˆöŽq‚ÌŒŸ“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.16)
›Œ´Ž¬D, –쑺’·‹v, ¬‘qˆêŒb, ŠÝ–ì‰l”ü, ŽR–{³—˜, Ö“¡ ˜i, ¬’r—ǘa, ‘¾“c—T‰î, ŽR‰º“N³, ŽR–{ —T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“–‰@‚É‚¨‚¯‚ép‘Oj¶ŒŸ‚ÆpŒã•a—Œ‹‰Ê‚Ì‘Šˆá‚ÉŠÖ‚·‚錟“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.16)
ŽŒÒ’¼Ž÷, ¼‰YŽi˜Y, g—Ñ~ˆê, X ‘וã, ’†‘ºƒ–ç, –k˜e é, X’J‘ì–ç
V‹KŠJ”R‘Ì‚ð—p‚¢‚½“ûŠàƒAƒƒ}ƒ^[ƒ[”Œ»‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ24‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2016.6.16)
Naoki Kanomata, Sachi Tanaka2, Kazuhiro Teramura, Ryosuke Yone, Yoshitake Hayashi, Takuya Moriya
BREAST MARKER ANTIBODY COCKTAIL IMMUNOCYTOCHEMISTRY FOR FINE NEEDLE ASPIRATION OF THE BREAST
The 19th International Congress of Cytology(‰¡•l)(2016.5.31)
Naoki Kanomata, Sakae Hata, Minako Fukuya, Takuya Moriya
BREAST CYTOLOGY @BREAST CASE 2
The 19th International Congress of Cytology(‰¡•l)(2016.5.30)
Kenji Yanoh, Yasuo Hirai, Daisuke Aoki, Atsuhiko Sakamoto, Takuya Moriya, Yoshiaki Norimatsu
PROPOSAL OF THE DESCRIPTIVE REPORTING FORMAT FOR ENDOMETRIAL CYTOLOGY DEVISED BY THE JSCC STUDY GROUP
The 19th International Congress of Cytology(‰¡•l)(2016.5.29)
•Ÿ‰®”ü“ÞŽq, ¬—Ñ”Ž‹v, ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, X’J‘ì–ç
‘ÞF‚µ‚½ƒpƒpƒjƒRƒƒEõF•W–{‚ÌÄõF‚ÌŽŽ‚Ý
‘æ57‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2016.5.29)
¬—Ñ]—˜, ècŒ´‘ñ—Y, •Ä —º—S, ›–ì–LŽq, •Ÿ‰®”ü“ÞŽq, ŽŒÒ’¼Ž÷, X’J‘ì–ç
ŠÇó‘Bǂ𔺂Á‚½‘B—l”X–EŠà‚Ì1—á
‘æ57‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2016.5.29)
›–ì–LŽq, •Ÿ‰®”ü“ÞŽq, •Ä —º—S, ¬—Ñ]—˜, ¬—Ñ”Ž‹v, ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, X’J‘ì–ç
Low-grade adenosquamous carcinoma‚Ì1—á
‘æ57‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2016.5.29)
X’J‘ì–çCˆî‹g‹MŠGC—é–Ø‘ˆê˜YCŽŒÒ’¼Ž÷
“ûŠà‚̃oƒCƒIƒ}[ƒJ[ŒŸõ:Œ»ó‚Æ«—ˆ“W–]
‘æ105‰ñ“ú–{•a—Šw‰ï‘‰ï(å‘ä)(2016.5.14)
ŽŒÒ’¼Ž÷C‹Ê“c•×C—é–Ø ‘ˆê˜YCˆî‹g‹MŠGC‹{’n’õKCX’J‘ì–ç
‘O—§‘BŠà‘gD‚̉摜‰ð̓f[ƒ^‚Æ,MRI‰æ‘œƒpƒ‰ƒ[ƒ^‚Ƃ̔äŠr‰ðÍ
‘æ105‰ñ“ú–{•a—Šw‰ï‘‰ï(å‘ä)(2016.5.12)
ŠÝ–ì‰l”ü, âV“¡˜i, ŽR‰º“N³, ¬‘qˆêŒb, ŽR–{³—˜, –쑺’·‹v, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç
isÄ”“ûŠàгŽÒ‚É‚¨‚¯‚鋹…ƒZƒ‹ƒuƒƒbƒN•a—Šw“I•]‰¿‚ÌŒŸ“¢
‘æ22‰ñ“ú–{“û‘B޾гŒ¤‹†‰ï(‚³‚¢‚½‚Ü)(2016.2.26)
X’J‘ì–ç, HŽR ‘¾
ƒJƒeƒSƒŠ[‚R‚ÌΊD‰»‚ð‚ǂ̂悤‚Ɉµ‚¤‚© “ûŠÇ“à•a•ς̕a—f’f‚ðŒê‚éI
‘æ25‰ñ“ú–{“ûŠà‰æ‘œŒ¤‹†‰ï(–¼ŒÃ‰®)(2016.2.21)
ŽÄè‚ä‚©‚è, Îì—TŽq, ¼”ö‘”ü, “V’JŒ\Œá, ‹ÚàV”Ž”ü, ŽO╉·, X’J‘ì–ç, —Ñ ŒõO
”X–E“à“û“ªŽî‚Ƃ̊ӕʂɓïa‚µ‚½“û“ª‘BŠÇŠà‚Ì1—á
‘æ77‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ï(•Ÿ‰ª)(2015.11.26)
“c’† KC¬’|ç‘ãCŽOD^—R”üC¬“cˆäŠwC”d’J‹KŽqCã“c‰À¢CŽ›‘ºˆê—TCŽŒÒ’¼Ž÷C—Ñ Ë„
“û‘BúŽh‹zˆø×–Ef‚É‚¨‚¯‚é p63/CK7/18/CK5/14 –Ɖu‘½dõF‚Ì—L—p«‚ÌŒŸ“¢
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(–¼ŒÃ‰®)(2015.11.22)
¬—Ñ”Ž‹vC›–ì–LŽqC•Ä —º—SC¬—Ñ]—˜C,ècŒ´‘ñ—YC•Ÿ‰®”ü“ÞŽqCŽŒÒ’¼Ž÷Cà_èŽüŽŸCX’J‘ì–ç
×–Ef‰æ‘œ‡¬‚Ì‚½‚߂̑½’iŠK˜IoŽB‰eŽ©“®‰»‚Ö‚ÌŽŽ‚Ý
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(–¼ŒÃ‰®)(2015.11.22)
›–ì–LŽqC•Ÿ‰®”ü“ÞŽqC•Ä —º—SC¬—Ñ]—˜C¬—Ñ”Ž‹vCècŒ´‘ñ—YC¼‘ºLŒ’CˆÉâX Œ÷CŽŒÒ’¼Ž÷CX’J‘ì–ç
”n”ö‚É”¶‚µ‚½‹H‚ÈŽîá‡2—á
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(–¼ŒÃ‰®)(2015.11.22)
ŽŒÒ’¼Ž÷C—é–Ø‘ˆê˜YCX’J‘ì–ç
“û‘B×–Ef‚ÌDCIS f’f‚Ì‚½‚ß‚ÌV‚½‚ȃAƒvƒ[ƒ` •ªŽq¶•¨Šw“IŒ©’n‚©‚ç‚Ý‚½DCIS
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(–¼ŒÃ‰®)(2015.11.22)
•ž•”^ˆË, —ÑG–¾, “c’†—¹, X’J‘ì–ç, “¡–{˜j
’·ŠúŠÔŒ´ˆö•s–¾‚ʼnº‘Ú’×ᇂðŒJ‚è•Ô‚µ16”NŒã‚É•a—Šw“I‚ÉŒŒŠÇ‰Š‚ðŠm”F‚µ“¾‚½1—á
‘æ66‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp‘å‰ï(_ŒË)(2015.10.31)
X’J‘ì–ç, —é–Ø‘ˆê˜Y, ŽŒÒ’¼Ž÷
ŽáŽèˆãŽt‚Ì‚½‚߂̂ª‚ñ•a—f’fuÀ@ƒQƒmƒ€Šw‚Ƃ̗Z‡ “û‚ª‚ñ‚̃Qƒmƒ€ˆÙ킪•a—‘gD‘œ‚É•\o‚·‚é@“àˆö«ƒTƒuƒ^ƒCƒv‰ð͂Ɨհ•a—
‘æ53‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(‹ž“s)(2015.10.29)
’†“‡‹`”Ž, Žž‰ªsŽO, ¼–äâX“y, –،[ƒ, ‰Í£’qÆ, ’†“‡—m, ‹g“c_Ži, ŽŒÒ’¼Ž÷, ’†‘º‰ëŽj, Šâ”ö”NN
ŽåäXŠÇ‚ÆŒð’ʂ̂ ‚é”X–E«äX_Œo“à•ª”åŠài‘å×–Ej‚̈ê—á
‘æ63‰ñ“ú–{Á‰»Ší‰æ‘œf’fŒ¤‹†‰ï(Š™‘q)(2015.9.12)
‹àŽq—Ï‹³, ’†‘ºM•F, ècŒ´ŒbŽq, ^“玌È, ŠF–؃Žq, â–{—R”ü, ŒÃì“TŽq, ”~“c—R•z, ’؈ä—TŽq, •ÐŽR–¾‰Ô, A–ØG–¾, X’J‘ì–ç
ƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒh‚ð—p‚¢‚½•a—“÷Šá•W–{Ž©ŒÈŠwKƒVƒXƒeƒ€‚ÌŠJ”
‘æ14‰ñ“ú–{ƒfƒWƒ^ƒ‹ƒpƒ\ƒƒW[Œ¤‹†‰ï(‘q•~)(2015.9.11)
²–ì—ÍÆ, ŽO‘î‹Mm, ‰HŠÔ—[‹IŽq, ‘º“c‘ì–ç, ’†‘º—²•¶, ‰º‰®_ˆê˜Y, X’J‘ì–ç, ‰–“c [
p‘O‚ÉŽq‹{‹ØŽî‚Ƃ̊ӕʂª¢“ï‚Å‚ ‚Á‚½ãO–ÑŠà‚̈êÇ—á
‘æ57‰ñ“ú–{•wl‰ÈŽîᇊw‰ï(ŠâŽè)(2015.8.7)
g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ‰º“oŽu˜N, ŽR‰º“N³
“ûŠà“à•ª”å—Ö@’ïR«”¶‚̃ƒJƒjƒYƒ€‚̉𖾂Ƃ»‚ÌŽ•ž‚ð–ÚŽw‚µ‚½Šî‘bŒ¤‹†
‘æ6‰ñìèˆã‰È‘åŠwŠwpW‰ï(‘q•~)(2015.8.1)
Ô’r—ml, ìè_ŽO, ŠF–؃Žq, ’†‘ºM•F, X’J‘ì–ç
–ÍŒ^‚ð—p‚¢‚½• •”GfƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹³ˆç
‘æ47‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(VŠƒ)(2015.7.25)
‹àŽq—Ï‹³, ’†‘ºM•F, ècŒ´ŒbŽq, ^“玌È, ŠF–؃Žq, â–{—R”ü, ŒÃì“TŽq, ”~“c—R•z, ’؈ä—TŽq, •ÐŽR–¾‰Ô, A–ØG–¾, X’J‘ì–ç
•a—“÷Šá•W–{Ž©ŒÈŠwKŽx‰‡ƒVƒXƒeƒ€‚ÌŠJ”@‘æ“ñ•ñ
‘æ47‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(VŠƒ)(2015.7.24)
g—Ñ~ˆêA¬’r—ǘaA‘¾“c—T‰îAŽR‰º“N³AŽŒÒ’¼Ž÷
ƒGƒXƒgƒƒQƒ“‚É‚æ‚é“ûŠàвזE‚̧Œä‚Æ“à•ª”å—Ö@’ïR«‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†
‘æ16‰ñƒzƒ‹ƒ‚ƒ“‚ÆŠàŒ¤‹†‰ï(Šò•Œ)(2015.7.10)
X’J‘ì–ç, ŽŒÒ’¼Ž÷, —L”nM”V, –{ŠÔ®Žq, ‘åˆä‹±‘ã, â’J‹MŽi, ”ò“c —z, ‹Ê錤‘¾˜N, V‘q’¼Ž÷, ‹g“cˆê–ç, ™]’mŽ¡
“ûŠà‚ÌKi-67ƒ‰ƒxƒŠƒ“ƒOƒCƒ“ƒfƒbƒNƒX‚ɑ΂·‚鎊“K‚ÈŒv‘ª–@‚ÌŒŸ“¢
‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2015.7.2)
g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ‰º“oŽu˜N, ŽR‰º“N³, ¬’r—ǘa, ‘¾“c—T‰î, X’J‘ì–ç
“ûŠàŽ¡—Öò‚É‚æ‚éŠàвזE‚̧Œä‹@\‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†
‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2015.7.2)
ŽŒÒ’¼Ž÷, g—Ñ~ˆê, ŽRŒû—Ï, X’J‘ì–ç
Z«”÷¬“û“ªŠà‚ÌVƒ}[ƒJ[BC-1514”Œ»‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ23‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(“Œ‹ž)(2015.7.2)
’†“‡‹`”Ž, ‹g“c_Ži, Žž‰ªsŽO, –،[ƒ, ‰Í£’qÆ, “ú–ìŒ[•ã, ’†“‡ —m, ’†‘º‰ëŽj, ˆÉâX Œ÷, X’J‘ì–ç
äX”ö•””÷¬ZŠà(T1N0M0)pŒãŽcäX‚É”¶‚µ‚½äX‘½”Šà‚̈ê—á
‘æ46‰ñ“ú–{äX‘ŸŠw‰ï‘å‰ï(–¼ŒÃ‰®)(2015.6.19)
¬—Ñ]—˜CècŒ´‘ñ—YC•Ä —º—SC›–ì–LŽqC•Ÿ‰®”ü“ÞŽqCŽŒÒ’¼Ž÷CX’J‘ì–ç
bó‘Bâ¿(Eƒ‚ƒ‹ƒ‰)Œ^“û“ªŠà‚Ì1—á
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(¼])(2015.6.14)
•Ÿ‰®”ü“ÞŽqCècŒ´‘ñ—YC›–ì–LŽqC•Ä —º—SC¬—Ñ]—˜C¬—Ñ”Ž‹vCŽŒÒ’¼Ž÷CX’J‘ì–ç
ŒŒ‰t¬“ü”ñ•wl‰ÈÞ—¿‚É‚¨‚¯‚é‰t󉻌Ÿ‘Ì×–Ef(LBC)–@‚Ì”äŠrŒŸ“¢
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(¼])(2015.6.14)
™ŽR—TŽqC²X–ØŠ°CX’J‘ì–ç
•wl‰È×–Ef¸“xŠÇ—‚É‚¨‚¯‚鎩“®‰»×–EfŽx‰‡ƒVƒXƒeƒ€‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(¼])(2015.6.14)
¬ŽR“WŽq, ”©“ñ˜Y, ŽŒÒ’¼Ž÷, Žž‰ªsŽO, –،[ƒ, ’†“‡‹`”Ž, •xŽR‹±s, m‰È‘yŽ¡, ‹g‰ª“Þ•äŽq, Œ´—Tˆê, ‹g“c_Ži, “ú–ìŒ[•ã
‘ÌŠOŽ®’´‰¹”g‚ªf’f‚É—L—p‚Å‚ ‚Á‚½t×–EŠà’_”X“]ˆÚ‚̈ê—á
‘æ103‰ñ“ú–{Á‰»Ší•aŠw‰ï’†‘Žx•”—á‰ï(ŽRŒû)(2015.6.13)
•Ä —º—SC•Ÿ‰®”ü“ÞŽqC›–ì–LŽqC¬—Ñ]—˜C¬—Ñ”Ž‹vCècŒ´‘ñ—YC“¡Œ´‰p¢C¼‘ºLŒ’Cà_èŽüŽŸCŽŒÒ’¼Ž÷
“ûŽ™‚É”¶‚µ‚½ˆÝŒ´”–¢nŠïŒ`Žî‚Ì1—á
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(¼])(2015.6.13)
X’J‘ì–çC‘O“cˆê˜YC–k‘º—²Ži
—̈æ•ʃKƒCƒhƒ‰ƒCƒ“‰ðà:“û‘B
‘æ56‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(¼])(2015.6.13)
X’J‘ì–ç, ŽŒÒ’¼Ž÷, g—Ñ~ˆê, —é–Ø ‹M, …–ì‹M”Œ, “¿“c³O
‘Šú“ûŠà‚ɑ΂·‚郌ƒNƒ`ƒ“”Œ»‚̈Ӌ`‚ÉŠÖ‚·‚é•a—Šw“IŒŸ“¢
‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï(–¼ŒÃ‰®)(2015.5.2)
X’J‘ì–ç
ƒfƒWƒ^ƒ‹ƒpƒ\ƒƒW[‚ÌŒ»ó‚Æ“W–]
‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï(–¼ŒÃ‰®)(2015.5.2)
ŽŒÒ’¼Ž÷, ŽRŒû —Ï, g—Ñ~ˆê, X’J‘ì–ç
“û‘BƒAƒ|ƒNƒŠƒ“•a•ςł̈â“`Žq•ψىð͂ɂæ‚éV‚½‚Èf’f–@‚ÌŠJ”
‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï(–¼ŒÃ‰®)(2015.4.30)
–q“cŒ[Žj, ”¨’†‰À“ÞŽq, X’J‘ì–ç, “¡“c—T”ü, ŒKŒ´ Œ’, דc[Žå, ŽO‹´’qŽq, ¼–ì‹gG
“û–[‰»¶Šà(–aŽ×–EŠà)‚̈ê—á
‘æ104‰ñ“ú–{•a—Šw‰ï‘‰ï(–¼ŒÃ‰®)(2015.4.30)
‹Ê“c•×, ŽŒÒ’¼Ž÷, ŽR–{ —º, í ‹`, ‹{’n’õK, ‰iˆä “Ö, ˆÉ“ŒŽ”\
‘O—§‘BŠà‚̔햌ŠOZ‚Ì—\‘ª‚É‚¨‚¯‚éhigh b-valueŠgŽU‹’²‘œ‚Ì—L—p«
‘æ103‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï(‹à‘ò)(2015.4.18)
Tamada Tsutomu, Sone Teruki, Kanomata Naoki, Yamamoto Akira, Kido Ayumu, Tanimoto Daigo, Ito Katsuyoshi
Utility of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in prostate cancer.
‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï(‰¡•l)(2015.4.16)
Tamada Tsutomu, Ito Katsuyoshi, Naoki Kanomata, Kanki Akihiko, Higaki Atsushi, Hayashida Minoru, Yamamoto Akira
Pancreatic Adenocarcinoma without Secondary Signs on Multiphasic Multidetector CT: Association with Clinical and Histopathologic features.
‘æ74‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï(‰¡•l)(2015.4.16)
Kurebayashi Junichi, Kanomata Naoki, Yamashita Tetsumasa, Shimo Toshiro, Moriya Takuya
Antitumor and anti-cancer stem cell activities of eribulin and antiestrogens in breast cancer cells.
14 th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer(Vienna, Austria)(2015.3.18)
ŽŒÒ’¼Ž÷
•a—f’f[—Lj««f’f¢“ï‚È•a•Ï
ìèˆã‰È‘åŠw•‘®•a‰@‚ª‚ñƒZƒ“ƒ^[‘æ16‰ñCancer Seminar(‘q•~)(2015.2.7)
X’J‘ì–ç
“ûŠÇ“à‘B«•a•ς̕a—f’f
‘æ103‰ñ“ú–{•a—Šw‰ï‘‰ï(‰«“ê)(2014.11.21)
¬—Ñ]—˜, ècŒ´‘ñ—Y, •Ä—º—S, r–Ø–LŽq, •Ÿ‰®”ü“ÞŽq, ŽŒÒ’¼Ž÷, X’J‘ì–ç
¸õ‚É”¶‚µ‚½’E•ª‰»Œ^މ–b“÷Žî‚Ì1—á
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‰ºŠÖ)(2014.11.8)
•Ÿ‰®”ü“ÞŽq, ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, X’J‘ì–ç
”A×–Ef•W–{‚̈—–@‚Æ×–EŒ`‘Ô‚ÉŠÖ‚·‚錟“¢
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‰ºŠÖ)(2014.11.8)
¬—Ñ”Ž‹v, r–Ø–LŽq, •Ä—º—S, ¬—Ñ]—˜, •Ÿ‰®”ü“ÞŽq, ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, X’J‘ì–ç
˜IoEÅ“_‘½d‡¬ˆ—‚æ‚é×–EW‰ò‘N–¾‰»‚ÌŽŽ‚Ý
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‰ºŠÖ)(2014.11.8)
’·“ˆ^‹I, Š}“‡“ÖŽq, “n•Ó‚Ý‚©, H•ÛM•F, X’J‘ì–ç
ŋ߂̕a—•ª—Þ‚Æ×–E‘œ@“û“ªó•a•ÏAƒAƒ|ƒNƒŠƒ“•a•ςȂÇA—Lj«‚ÌŠÓ•Ê“_‚ɂ‚¢‚Ä@“û‘B”S‰tŽY¶«•a•ςɂ¨‚¯‚é—Lj««‚ÌŠÓ•Ê“_‚ɂ‚¢‚Ä
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‰ºŠÖ)(2014.11.8)
ŽŒÒ’¼Ž÷
ŋ߂̕a—•ª—Þ‚Æ×–E‘œ@“û“ªó•a•ÏAƒAƒ|ƒNƒŠƒ“•a•ςȂÇA—Lj«‚ÌŠÓ•Ê“_‚ɂ‚¢‚Ä@“û‘BŽîᇕa—•ª—ނ̕ϑJ
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‰ºŠÖ)(2014.11.8)
“¡–{˜j, –q–ì‰pˆê, ŽŒÒ’¼Ž÷, ì–{–L
Transient neonatal pustular melanosis‚Ì’jŽ™—á
‘æ66‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”Šwp‘å‰ï(‚¼)(2014.11.8)
‚‹´‰ëŽq, –{“cƒŽq, œA£çŒbŽq, X’J‘ì–ç, ùŽO“¿
‹}‘¬‚È‘‘å‚ð”F‚ß‚½“û‘B–aŽ×–EŠà‚Ì1—á
‘æ24‰ñ“ú–{“ûŠàŒŸfŠw‰ïŠwp‘‰ï(‘O‹´)(2014.11.7)
‰HŠÔ—[‹IŽq, ™Œ´™Œ´, ²–ì—ÍÆ, ŽO‘î‹Mm, ‘º“c‘ì–ç, •y¼‘ñŽ¡, ’†ˆä—Sˆê˜Y, ’†‘º—²•¶, ‰–“c[, ˆËŒõ‘å—S, “¡–{‘s”ª, ”Œ´’¼Ž÷, ¼‘ºLŒ’, X’J‘ì–ç, ‰º‰®_ˆê˜Y
SLE‡•¹”DP‚ɂăIƒLƒVƒgƒVƒ“‚É”½‰ž‚¹‚¸–ü’…‘Ù”Õ‚ð”F‚ß‚½ˆêÇ—á
‘æ22‰ñ“ú–{‘Ù”ÕŠw‰ï(‹ž“s)(2014.10.3)
²–ì—ÍÆ,ŽO‘î‹Mm,X’J‘ì–ç,‰–“c[
• o‹¾ŽèpŽž‚É‹ô‘R”Œ©‚³‚ꂽ• –Œ”dŽí«•½ŠŠ‹ØŽîǂ̈ê—á
‘æ54‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï(ŽŽ™“‡)(2014.9.11)
g—Ñ~ˆêAŽŒÒ’¼Ž÷AŽR‰º“N³A‰º“oŽu˜NAX’J‘ì–ç
ƒGƒŠƒuƒŠƒ“‚Æ“à•ª”å—Ö@–ò‚Ì“¯Žž•¹—pŒø‰Ê‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢
‘æ23‰ñ“ûŠàŠî‘bŒ¤‹†‰ï(’}”g)(2014.7.26)
‹{’n’õK, ŽŒÒ’¼Ž÷, ²“¡–õŽj, ‹à¯“N, •ŸŒ³˜a•F, ŠC•”ŽOŽq, “¡ˆä’q_,í‹`, ‰¡ŽRŒõ•F, X’J‘ì–ç, ‰iˆä“Ö
ŒŒŠÇV¶—}§ˆöŽqVasohibin-1‚Ít×–EŠàpŒã‚Ì”ñÄ”‚Ì—\‘ªƒ}[ƒJ[‚Å‚ ‚é
‘æ44‰ñtŠàŒ¤‹†‰ï(“Œ‹ž)(2014.7.21)
Ô’r—ml,ìè_ŽO,ŠF–؃Žq,’†‘ºM•F,X’J‘ì–ç
ŠÌäBŽîG’m‚ð–Ú“I‚Æ‚µ‚½ƒ}ƒlƒLƒ“‚ÌŠJ”
‘æ46‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(˜a‰ÌŽR)(2014.7.19)
‰HŠÔ—[‹IŽq, ‘º“c‘ì–ç, ²–ì—ÍÆ, ™Œ´–í, Γc„, ‘v”üŒº, •Ÿ‰ÆM“ñ, ”~–{‰ë•F, •x¼‘ñŽ¡, ’†ˆä—Sˆê˜Y, ‰–“c[, ‰º‰®_ˆê˜Y, X’J‘ì–ç, ’†‘º—²•¶
2”NŒã‚É•½ŠŠ‹Ø“÷Žî‚Æ‚µ‚ÄÄ”‚µ‚½LŠÔ–Œ“à”ˆçˆ««“x•s–¾‚È•½ŠŠ‹Ø«ŽîᇂÌ1—á
‘æ56‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(‰F“s‹{)(2014.7.17)
ŽŒÒ’¼Ž÷,g—Ñ~ˆê,X’J‘ì–ç
pŒãƒgƒ‰ƒXƒcƒYƒ}ƒu“Š—^‚ðŽó‚¯‚Ä‚¢‚éHER2—z«Ç—á‚Å‚Ì pHER3 ‚ƃgƒ‰ƒXƒcƒYƒ}ƒu’¼Úƒ‰ƒxƒ‹–@–ƉuõF‚ÌŒŸ“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.11)
•½ì‹v,ŠÃ—˜³˜a,‰ª‚«‚Ü‚±,–Ø‘º“¹•v,•“cŒ³”Ž,X’J‘ì–ç,“n•Ó‚Ý‚©,Š}“‡“ÖŽq,H•ÛM•F,’·“ˆ^‹I
“–‰@‚Å‚ÌF‘f–@’P“Ƃɂæ‚éƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß¶ŒŸ,“Á‚ɋߖT‚Ì”ñõFƒŠƒ“ƒp߂̓]ˆÚ󋵂Ɋւ·‚錟“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.11)
X’J‘ì–çC—L”nM”VC‘åˆä‹±‘ãCŠpŽÉŠwsCŽŒÒ’¼Ž÷Câ’J‹MŽiC‹Ê錤‘¾˜NCV‘q’¼Ž÷C–{ŠÔ®ŽqC‹g“c ˆê–çC”ò“c—z
2012”N“x“ú–{“ûŠàŠw‰ï”ÇŒ¤‹†ÅI•ñ@Ki-67‚Ì‘ª’è•]‰¿‚Ì•W€‰»‚ÉŠÖ‚·‚錤‹†
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.11)
ŽR‰º“N³,g—Ñ~ˆê,âV“¡˜i,‘¾“c—T‰î,¬’r—ǘa,‰º“oŽu˜N,ŽR–{—T,“c’†Ž_,ŽŒÒ’¼Ž÷,X’J‘ì–ç,•û—Ç•½,ì–쎬D,XÊŽq
“û“ªE“û—Ö‰·‘¶“û–[ØœpŒã‚̋NJĔƒŠƒXƒNˆöŽq‚ÌŒŸ“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
ŠÃ—˜³˜a,•½ì‹v,‰ª‚«‚Ü‚±,X’J‘ì–ç
“û–[‰·‘¶pŒã‚É Paget •a‚ð”Ç‚µ‚½2Ç—á‚ÌŒŸ“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
’†“‡ˆê‹B,“¡–{‘׋v,X’J‘ì–ç
“û–[’´‰¹”g
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
V‘q’¼Ž÷,â’J‹MŽi,—L”nM”V,‘åˆä‹±‘ã,–{ŠÔ®Žq,ŽŒÒ’¼Ž÷,‹g“cˆê–ç,ŠpŽÉŠws,‹Ê錤‘¾˜N,X’J‘ì–ç,ŒF LŽ},Šâ–{‚s,™]’mŽ¡
•a—ˆãŠÔ‚Ì Ki67 ‚̈ê’v—¦‚ÌŒŸ“¢ Ki67 ƒŠƒ“ƒOƒXƒ^ƒfƒB‚ÌŒ‹‰Ê‚©‚ç
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
”ò“c—z,ⓌŒ’ŽŸ,™“c“Ö˜Y,‘O“c’qŽ¡,A“c‹KŽj,¼‰eºˆê,’†¼Œì,–Ø“¡ŽŒÈ,‘åžK—SŽ¡,¼‘º—ŒbŽq,‹{è—´•F,‘åé—R”ü,ìŒû‰pr,ˆä㔎“¹,‹VŒ’“ñ˜Y,X’J‘ì–ç
Ki67 ‚Ì–Ú‘ª5’iŠK”»’è (eye-5) ‚ÍŠÈ’P‚ÅAlabeling ‚Ì‘ã—p‚ƂȂèA”»’èŽÒŠÔE”»’èŽÒ“àŠi·‚à‚È‚¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
âV“¡˜i,g—Ñ~ˆê,¬’r—ǘa,‘¾“c—T‰î,ŽR‰º“N³, “oŽu˜N,ŽR–{ —T,“c’†Ž_,ŽŒÒ’¼Ž÷,X’J‘ì–ç, ì–ì Ž¬D,XÊŽq,•û—Ç•½
Žîᇫ”xÇðǂɂæ‚éŒÄ‹z¢“ƒGƒŠƒuƒŠƒ“‚É‚æ‚è‰ü‘P‚µ‚½Ä”“ûŠà‚Ì1—á
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
‹g“cˆê–ç,ŒN“‡ˆÉ‘¢,ŽŒÒ’¼Ž÷,X’J‘ì–ç
Žèp•W–{‚É‚¨‚¯‚é Ki]67labelingindex ‚Íj¶ŒŸŒŸ‘̂őã—p‚Å‚«‚é‚©?
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
X’J‘ì–ç,ŽŒÒ’¼Ž÷,²X–Ø—¢Ø,’–’J‰Ã_
Z«“ûŠÇŠà‚ɑ΂·‚é Ki]67 ‘ª’è–@‚Ì•W€‰»‚ÉŠÖ‚·‚錟“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
ˆÉ“¡~,ŒN“‡ˆÉ‘¢,‹g“cˆê–ç,ŽŒÒ’¼Ž÷,X’J‘ì–ç
“ûŠà‚ÌL‚ª‚èf’f‚É‚¨‚¯‚é’´‰¹”gŽ©“®ƒuƒŒƒXƒgƒ{ƒŠƒ…[ƒ€ƒXƒLƒƒƒi (ABVS) ‚Ì—L—p«
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
’†ŽR‰Â“ìŽq,–îŒ`а,‹g“c“Ö,—Ñ’¼‹P,X’J‘ì–ç,—é–Ø‚—S,ŽR“à‰pŽq
ŠjƒOƒŒ[ƒg‚Æ Ki]67 ‚̑傫‚Ș¨—£‚ðŽ¦‚µ‚½“ûŠàÇ—á‚ÌŒŸ“¢
‘æ22‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‘åã)(2014.7.10)
g—Ñ~ˆê,ŽŒÒ’¼Ž÷,ŽR‰º“N³,‰º“oŽu˜N,–쑺’·‹v,X’J‘ì–ç
ƒGƒXƒgƒƒQƒ“Š´Žó«“ûŠà×–E‚É‚¨‚¯‚éƒGƒXƒgƒƒQƒ“‚ÌŠàŠ²×–E§Œä‹@\
‘æ15‰ñƒzƒ‹ƒ‚ƒ“‚ÆŠàŒ¤‹†‰ï(å‘ä)(2014.7.4)
²“¡ —F”ü, –ž‰º ~’n, ª’à K•ä, —é–Ø —R—œ“Þ, ‹ßàV Œ¤˜Y, ´… “¹¶, ˆÀ“c ŽÀ, X’J ‘ì–ç, ¡–ì —Ç
–¢•ª‰»«õŠÔŽ¿«Žîᇂ̈ê—á
‘æ85‰ñé‹ÊŽY‰È•wl‰ÈŠw‰ï é‹ÊŒ§ŽY•wl‰Èˆã‰ï •½¬26”N“x‘OŠúŠwpW‰ï(é‹Ê)(2014.6.28)
¼–äâXŽm, ’†“‡‹`”Ž, –،[ƒ, Žž‰ªsŽO, ¬ŽR“WŽq, ²X–Ø‹±, ‰Í£’qÆ, •xŽR‹±s, m‰È‘y–è, ‹g‰ª“Þ•äŽq, Œ´—Tˆê, ‹g“c_Ži, “ú–ìŒ[•ã, ˆ¢•”r–ç, ’†“‡—m, ’†‘º‰ëŽj, X’J‘ì–ç
‹}«dÇäX‰Š‚ðŒ_‹@‚É”Œ©‚³‚ꂽA\“ñŽw’°“û“ª•”Šà‚̈ê—á
‘æ101‰ñ“ú–{Á‰»Ší•aŠw‰ï’†‘Žx•”—á‰ï(‰ªŽR)(2014.6.21)
‰º“oŽu˜N, g—Ñ~ˆê, •û—Ç•½, Ö“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŽR‰º“N³, ŽR–{—T, “c’†Ž_, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“ûŠàbó‘B“]ˆÚ‚Ì2—á
‘æ113‰ñ‰ªŽRˆãŠw‰ï‘‰ï(‰ªŽR)(2014.6.7)
X’J‘ì–ç, ‘O“cˆê˜Y, –k‘º—²Ži
—̈æ•ʃKƒCƒhƒ‰ƒCƒ“@“û‘B
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.7)
ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, •Ä—º—S, r–Ø–LŽq, ¬—Ñ]—˜, •Ÿ‰®”ü“ÞŽq, ˆÉâXŒ÷, à_èŽüŽŸ, X’J‘ì–ç
Œûo’ê‚É”¶‚µ‚½ŒÇ—§«üˆÛ«Žîᇂ̈ê—á
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.7)
r–Ø–LŽq, ècŒ´‘ñ—Y, ¬—Ñ”Ž‹v, •Ÿ‰®”ü“ÞŽq, ¬—Ñ]—˜, •Ä—º—S, ˆÉâXŒ÷, ŽŒÒ’¼Ž÷
މ–b×–EŒ^”A˜Hã”çŠà‚Ì1—á
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
X’J‘ì–ç
“û‘B×–Ef@f’f‚É–ð—§‚ÂŒ©•ûE•ñ‚ÌŽd•û
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
–î”[Œ¤“ñ, •½ˆäN•v, –ؑå•ã, X’J‘ì–ç, â–{–s•F
“ú–{‘“à‚É‚¨‚¯‚éŽq‹{“à–Œ×–Ef‚ÌŠ´“xE“ÁˆÙ“xŠm—§‚ÆŒüã‚Ì‚½‚߂̕ûŒü«
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
X’J ‘ì–ç, ‘ë–{ ‰ë•¶, “cK ‘ô–, ŽO‘î ^Ži
ˆã—ÈÀ‘SƒZƒ~ƒi[@ŽÀ—á‚ÉŠw‚Ô
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
X’J‘ì–ç, ™ŽR—TŽq, ²X–ØŠ°
Ž©“®‰»×–EfŽx‰‡ƒVƒXƒeƒ€Žg—p‚É‚æ‚é•wl‰È×–Ef‚̸“xŠÇ—‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
•Ä—º—S, •Ÿ‰®”ü“ÞŽq, r–Ø–LŽq, ¬—Ñ]—˜, ¬—Ñ”Ž‹v, ècŒ´‘ñ—Y, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“û‘B×–EfŒŸ‘̂ɂ¨‚¯‚éADH-5R‘̂ɂæ‚鑽dõF‚ÌŠî‘bŒŸ“¢
‘æ55‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2014.6.6)
•û—Ç•½, ‰º“oŽu˜N, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŽR‰º“N³, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, X’J‘ì–ç
“–‰@‚ÅŒoŒ±‚µ‚½“ûŠàbó‘B“]ˆÚ‚Ì2Ç—á
‘æ26‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï(–¼ŒÃ‰®)(2014.5.22)
ŽR‰º“N³, “c’†Ž_, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ‰º“oŽu˜N, ŽR–{—T, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, X’J‘ì–ç, •û—Ç•½, ì–쎬D, XÊŽq
bó‘B–„–v•›bó‘B‚ð”F‚ß‚½‘±”«•›bó‘B‹@”\˜´iÇ‚Ì2—á
‘æ26‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï(–¼ŒÃ‰®)(2014.5.22)
”ò“c—z, ⓌŒ’ŽŸ, ™“c“Ö˜Y, ‘O“c’qŽ¡, A“c‹KŽj, ¼‰eºˆê, ’†¼Œì, ¼‘º—ŒbŽq, –Ø“¡ŽŒÈ, ‹{è—´•F, ‘åžK—SŽ¡, ‘åé—R”ü, X’J‘ì–ç
“ûŠà‚ÌKi67(MIB-1)1,000ŒÂ”‚¦‚Ă܂·‚©?ŠÈ’P‚È–Ú‘ª”»’è(eye-5)‚ÍAlabeling index(LI)‚Ì‘ã—p‚ƂȂé
‘æ103‰ñ“ú–{•a—Šw‰ï‘‰ï(L“‡)(2014.4.25)
ŽRè—², ŽðˆäN—T, X’J‘ì–ç, ˆÉ“¡’q—Y
“ûŠÇ“à‘B«•a•ς𔺂Á‚½“û‘B–aŽ×–EŠà‚Ì1—á
‘æ103‰ñ“ú–{•a—Šw‰ï‘‰ï(L“‡)(2014.4.24)
‹Ê“c•×, ŽŒÒ’¼Ž÷, í‹`, ‹{’n’õK, ‰iˆä“Ö, ˆÉ“ŒŽ”\
‘O—§‘BŠà‚ÌŽîᇌŸo‚¨‚æ‚ш««“x‚Ì•]‰¿‚É‚¨‚¯‚éhigh b-valueŠgŽU‹’²‘œ‚Ì—L—p«
‘æ102‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï(_ŒË)(2014.4.24)
ŽŒÒ’¼Ž÷, ‹{’n’õK, ¬¼³‘ã, X’J‘ì–ç
¸‘ƒã‘ÌŠà‚Ì2—á
‘æ3‰ñ“ú–{”å”AŠí•a—Œ¤‹†‰ï(“Œ‹ž)(2014.3.28)
ŽŒÒ’¼Ž÷
•a—[–ƉuõF‚Ìf’f—L—p«‚ÆŒÀŠE
ìèˆã‰È‘åŠw•‘®•a‰@‚ª‚ñƒZƒ“ƒ^[‘æ14‰ñCancer Seminar(‘q•~)(2014.2.8)
‰º“oŽu˜N, g—Ñ~ˆê, •û—Ç•½, âV“¡˜i, ‘¾“c—T‰î, ¬’r—ǘa, ŽR‰º“N³, ŽR–{—T, “c’†Ž_, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“ûŠàbó‘B“]ˆÚ‚Ì2—á
‘æ176‰ñ‰ªŽRŠO‰È‰ï(‰ªŽR)(2014.1.18)
ŽŒÒ’¼Ž÷
“ûŠàVASH2”Œ»‚̖Ɖu‘gDŠw“IŒŸ“¢
‘æ9‰ñVasohibinŒ¤‹†‰ï(å‘ä)(2014.1.11)
X’J ‘ì–ç, ŽŒÒ’¼Ž÷
“ûŠà‚̌•ʉ»Ž¡—Âð–ÚŽw‚µ‚½•a—E×–EŠw“I•]‰¿‚̈Ӌ`
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘åã)(2013.11.3)
¬—Ñ ”Ž‹v, ècŒ´ ‘ñ—Y, •Ÿ‰® ”ü“ÞŽq, ”© žÄ, HŽR —², X’J ‘ì–ç
“û–[‚É”¶‚µ‚½Merkel×–EŠà‚Ì1—á
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘åã)(2013.11.2)
r–Ø –LŽq, ŽŒÒ’¼Ž÷, ècŒ´ ‘ñ—Y, ¬—Ñ ”Ž‹v, •Ÿ‰® ”ü“ÞŽq, ¬—Ñ ]—˜, •Ä —º—S, ¼‘º LŒ’, “¡Œ´ ‰p¢, X’J ‘ì–ç, à_è ŽüŽŸ, ’蕽 ‹g“s
àh–E«ƒŠƒ“ƒpŽî‚ɌÓTŒ^ƒzƒWƒLƒ“ƒŠƒ“ƒpŽî‚ª‡•¹‚µ‚½1—á
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘åã)(2013.11.2)
–î”[ Œ¤“ñ, •½ˆä N•v, Â–Ø ‘å•ã, â–{ –s•F, X’J ‘ì–ç
“à–Œ×–Ef‚ÌPitfallsŽ•ž‚ð–ÚŽw‚µ‚Ä@ˆ««‚Ƃ̈Ӌ`‚ªŠm’è‚Å‚«‚È‚¢ˆÙŒ^“à–Œã”ç×–E‚ÉŠÖ‚·‚錟“¢‚ð’†S‚É ˆ««‚Ƃ̈Ӌ`‚ªŠm’è‚Å‚«‚È‚¢ˆÙŒ^“à–Œã”ç×–E(ATECj
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(‘åã)(2013.11.2)
’؈ä—TŽq, ’†‘ºM•F, ècŒ´ŒbŽq, m‰ÈKŽq, ‹àŽq—Ï‹³, ŒÃì“TŽq, ^“玌È, ècŒ´‘ñ—Y, Œ}—R—˜Žq, X’J‘ì–ç, A–ØG–¾
Šw“àLAN‚ð—˜—p‚µ‚½‰ð–U‘gDŠw•â•‹³Þ‚̧ì
‘æ45‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(ç—t)(2013.7.26-27)
‹àŽq—Ï‹³, ’†‘ºM•F, ^“玌È, ècŒ´ŒbŽq, m‰ÈKŽq, ŠF–؃Žq, â–{—R”ü, ŒÃì“TŽq, ’|‘º—R•z, ’؈ä—TŽq, X’J‘ì–ç, A–ØG–¾
ˆê”ÊŽs–¯‚ð‘ÎÛ‚Æ‚µ‚½ˆãŠw“Wަ‚ÉŠÖ‚·‚錟“¢
‘æ45‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(ç—t)(2013.7.26-27)
”ò“c —z, ‘åé —R”ü , ìŒû ‰pr, ˆäã ”Ž“¹, “cŒû Œ’ˆê , ‘å–ì ^Ži, •½ì ‹v, X’J ‘ì–ç
Ki67•]‰¿•û–@‚Ì•W€‰»‚ÉŒü‚¯‚Ä`–Ú‘ª”»’è‚͊ȕւÅÄŒ»«‚ª‚ ‚èAlabeling index(LI)‚Ì‘ã—p‚ƂȂé
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.29)
•½ì ‹vC“càV “ÄC‰ª ‚«‚Ü‚±C–Ø‘º “¹•vC•“c Œ³”Ž, X’J ‘ì–çCH•Û M•FC’·“ˆ ^‹ICˆ¢•Û ¹Ž÷ CŽÀ•û ˆê“T
“û‘B”S‰t᎗lŽîᇂÆf’fŒã‚َ̈ž«‚Ì“ûŠà”¶ó‹µ
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.28)
’†ì ”ü»Žq, Ⓦ —Ç”ü, ù ŽO“¿, X’J ‘ì–ç, ’O• Í, ‚ˆä ƒ`ƒJƒR, “cŠ —R‹IŽq, •’m _˜a, X–{ ‰ë”ü, ŒÃì ‘¸Žq, ’r“c ^—R”ü
Triple Negative“ûŠà‚É‚¨‚¯‚éTS,DPD”Œ»‚ÌŒŸ“¢
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.28)
ŽR‰º“N³, g—Ñ~ˆê, X’J‘ì–ç, ŽŒÒ’¼Ž÷, ‰€”ö”ŽŽi, “c’†Ž_, ’Å–ØŽ —Y, ŽR–{—T, …“¡»Žq, ‰º“oŽu˜N, “¡ˆä´, ‘¾“c—T‰î, ¬’r—ǘa, Ö“¡˜i
ƒGƒXƒgƒƒQƒ“Š´Žó«“ûŠà×–E‚É‚¨‚¯‚é“à•ª”å—Ö@–ò‚Ì×–E‘B•À‚Ñ‚ÉŠàŠ²×–E§Œäì—p
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.28)
X’J‘ì–ç
2012”N“x“ú–{“ûŠàŠw‰ï”ÇŒ¤‹†‰Û‘è’†ŠÔ•ñuKi-67 ‚Ì‘ª’è•]‰¿‚Ì•W€‰»‚ÉŠÖ‚·‚錤‹†v
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
X’J‘ì–çCŽŒÒ’¼Ž÷
DCIS‚Ì•a—f’f:ŋ߂̘b‘è
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
‚‹´ —T™Z, “c’† —², •ÐŽR ˜a‹v, ‰œ‘º ˜a³, ‰““¡ GŽq, X’J ‘ì–ç
‘½Ê‚È•a—‘gD‘œ‚ð’æ‚µ‚½“û‘B–aŽ×–EŠà‚Ì 1 —á
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
‚‹´ ‰ëŽq, Œ“¼ ”üK, –{“c ƒŽq, Ⓦ —Ç”ü, X’J ‘ì–ç, ù ŽO“¿
DCIS‰æ‘œŠŒ©‚Æ Ki67 ‚ðŠÜ‚ß‚½•a—‘gDŠw“Iˆ««“x‚ÌŒŸ“¢
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
“¡ˆä´, X’J‘ì–ç, ’Å–ØŽ —Y, ‰€”ö”ŽŽi, ¬’r—ǘa, ‘¾“c—T‰î, ŽR‰º“N³, ‰º“oŽu˜N, …“¡»Žq, ŽR–{—T, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷
‘«ŠÖß‰Š‚Æ‰º‘ÚŒ‹ß«g”Á‚𔺂Á‚½“÷‰èŽî«“û‘B‰Š‚Ì1—á
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
…“¡»Žq, g—Ñ~ˆê, ŽR‰º“N³, ‰€”ö”ŽŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç, “c’†Ž_, ’Å–ØŽ —Y, ŽR–{—T, ‰º“oŽu˜N, “¡ˆä´, ‘¾“c—T‰î, ¬’r—ǘa
pŒã•╉»ŠwEƒgƒ‰ƒXƒcƒYƒ}ƒu—Ö@‚ðŽó‚¯‚½HER2—z«“ûŠàгŽÒ‚ÌÄ”—\‘ªˆöŽq
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
X’J‘ì–ç, ŽŒÒ’¼Ž÷, “c‰ª’mŒb, ã“c”üç, —ÑŒõO, ¡“cFŽq, •½ì‹v, ŒN“‡ˆÉ‘¢, g—Ñ~ˆê, ‰€”ö”ŽŽi
p‘O–ò•¨—Ö@Ž{sŒã‚ÌpCR•]‰¿‚ÉŠÖ‚·‚é•a—Šw“IŒŸØ
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
ŽŒÒ’¼Ž÷, g—Ñ~ˆê, ŽRŒû—Ï, ‰€”ö”ŽŽi, X’J@‘ì–ç
¬‡Œ^Z«”÷¬“û“ªŠà‚ÌŒ`‘Ô“I‚ɈقȂ鑜‚ðŽ¦‚·Še¬•ª‚Å‚ÌDNAƒ}ƒCƒNƒƒAƒŒƒCƒ`ƒbƒv”äŠr‰ðÍ
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
‰º“oŽu˜N, g—Ñ~ˆê, ŽR‰º“N³, ŽR–{—T, “c’†Ž_, ‰€”ö”ŽŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç
p‘OEC—Ö@{ƒhƒZƒ^ƒLƒZƒ‹EƒhƒLƒVƒtƒ‹ƒŠƒWƒ“—Ö@‚ÌŒø‰Ê—\‘ªˆöŽq
‘æ21‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(•l¼)(2013.6.27)
ŒÃì“TŽq, ’†‘ºM•F, â–{—R”ü, ”~“c—R•z, ’؈ä—TŽq, ‹àŽq—Ï‹³, m‰ÈKŽq, ŠF–؃Žq, ècŒ´ŒbŽq, X’J‘ì–ç, A–ØG–¾
ƒAƒCƒLƒƒƒbƒ`Œø‰Ê‚ðŠú‘Ò‚µ‚½ƒTƒCƒGƒ“ƒXƒAƒSƒ‰2012‚Ö‚Ìo“W `l‘̂ɂƂ«‚ß‚¯IƒhƒLƒhƒLƒn[ƒgƒ‰ƒ“ƒh`
‘æ32‰ñ“ú–{“WަŠw‰ïŒ¤‹†‘å‰ï(•ºŒÉ)(2013.6.15)
ŽŒÒ ’¼Ž÷Cg—Ñ ~ˆêC‰€”ö ”ŽŽiCX’J ‘ì–ç
2d–ƉuõF–@‚ƃfƒWƒ^ƒ‹‰æ‘œ‰ðÍ‚ð—p‚¢‚½Ki-67 index•]‰¿
‘æ102‰ñ“ú–{•a—Šw‰ï‘‰ï(ŽD–y)(2013.6.7)
ˆÀ”{ –MŽqC—Ñ “¿^‹gC–؉º ’¼]CˆÀˆä t“ÞC“c’† ”º“TC’†ŽR •qKC–î–ì —mC‹yì «OC¼–{ ŒbC‰iˆÀ •CX’J ‘ì–çC•Ÿ‰ª ‡–ç
‹Øã”笕ª‚̬‰óŽ€‘ƒ‚â‚‚¢‘B”\‚ðŽ¦‚·‘B‹Øã”çŽî‚̈ê—á
‘æ102‰ñ“ú–{•a—Šw‰ï‘‰ï(ŽD–y)(2013.6.6)
”© žÄCX’J ‘ì–çCŽŒÒ ’¼Ž÷
“û‘BúŽh‹zˆø×–Ef‚Ö‚ÌLBC i Liquid-based cytologyj –@‚̉ž—p „Ÿ ‘gD\’z‚©‚ç‚Ý‚½×–EŠŒ©‚̓ǂݕû „Ÿ
‘æ102‰ñ“ú–{•a—Šw‰ï‘‰ï(ŽD–y)(2013.6.6)
X’J‘ì–çCŽŒÒ ’¼Ž÷C‘åˆä ‹±‘ãCâ’J ‹MŽiCŒ´“c ‘åC–xˆä —ŠGC‘O“c ˆê˜YCŽRŒû —ÏCŠ}“‡ “ÖŽqC‘åX ¹ŽqC¬’Ë —SŽi
ƒo[ƒ`ƒƒƒ‹‰æ‘œ‚ð—p‚¢‚½A“û‘B޾г‚ɑ΂·‚é•a—ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚̸“x
‘æ102‰ñ“ú–{•a—Šw‰ï‘‰ï(ŽD–y)(2013.6.6)
•Ÿ‰® ”ü“ÞŽq, ”© žÄ, r–Ø –LŽq, •Ä —º—S, ¬—Ñ ”Ž‹v, ècŒ´ ‘ñ—Y, ˆÉâX Œ÷, HŽR —², à_è ŽüŽŸ, ŽŒÒ ’¼Ž÷
‹¹…’†‚ÉoŒ»‚µ‚½˜’ÅÒõŽî‚̈ê—á
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2013.6.2)
–î”[ Œ¤“ñ, •½ˆä N•v, Â–Ø ‘å•ã, X’J ‘ì–ç, â–{ –s•F
‹LqŽ®Žq‹{“à–Œ×–Ef•ñ—lŽ®
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2013.6.2)
”© žÄ, •Ÿ‰® ”ü“ÞŽq, ŽŒÒ ’¼Ž÷, X’J ‘ì–ç
“û‘BLBC–@‚Ì×–Ef@‘gD\’z‚©‚ç‚Ý‚½×–EŠŒ©‚̓ǂݕû
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2013.6.2)
X’J‘ì–ç
“û‘BDCISE‹«ŠE•a•ς̗հ•a—‚Æ×–E‘œ
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2013.6.2)
ècŒ´ ‘ñ—Y, •Ä —º—S, r–Ø –LŽq, •Ÿ‰® ”ü“ÞŽq, ”© žÄ, ˆÉâX Œ÷, ŽŒÒ ’¼Ž÷, à_è ŽüŽŸ, X’J ‘ì–ç
“ûŠàpŒã‚ɂ݂ç‚ꂽŽîᎂðŠà‚ÆŒ©Œë‚Á‚½—Ç«Š¾‘B«Žîᇂ̈ê—á
‘æ54‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2013.6.1)
X’J‘ì–ç
ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“13ƒf—ÂɊˆ‚©‚·„ ƒJƒeƒSƒŠ[3‚ÌΊD‰»‚ðŒ@‚艺‚°‚éF‰æ‘œf’f‚Ì“Á’¥‚Æ‘Îô‚ɂ‚¢‚Ä@ƒJƒeƒSƒŠ[3‚ÌΊD‰»F•a—‘gD‘œ‚Ƃ̑Δä
“ú–{’´‰¹”gˆãŠw‰ï‘æ86‰ñŠwpW‰ï(‘åã)(2013.5.25)
X’J‘ì–ç
ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“12 ƒ‹³ˆç‚ÉŠˆ‚©‚·„ •S‰Ô㇗I “û–[’´‰¹”gŒŸ¸—pŒê@“û–[’´‰¹”gŒŸ¸—pŒêF•a—‚Ì—§ê‚©‚ç
“ú–{’´‰¹”gˆãŠw‰ï‘æ86‰ñŠwpW‰ï(‘åã)(2013.5.25)
ŽŒÒ’¼Ž÷C•“c’¼lCX’J‘ì–ç
’W–¾×–E¬•ª‚Æ”÷¬“û“ªóE‹U“û“ªó¬•ª‚Æ‚ª”F‚ß‚ç‚ꂽ•ª—Þ•s”\Œ^t×–EŠà‚Ì1—á
‘æ2‰ñ“ú–{”å”AŠí•a—Œ¤‹†‰ï(“Œ‹ž)(2013.2.2)
’†‘º M•F, ècŒ´ ŒbŽq, m‰È KŽq, ’Øˆä —TŽq, ècŒ´ ‘ñ—YCŒ}@—R—˜Žq, X’J ‘ì–ç, A–Ø G–¾
‰ð–U‘gDŠwŽÀK‚É‚¨‚¯‚éƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒh‚Ì‹³ˆçŒø‰Ê‚ÌŒŸ“¢
‘æ11‰ñ“ú–{ƒeƒŒƒpƒ\ƒƒW[Eƒo[ƒ`ƒƒƒ‹ƒ}ƒCƒNƒƒXƒRƒs[Œ¤‹†‰ï‘‰ï(“ß”e)(2012.12.14)
“c’†—[‹IŽq, ²–ì—ÍÆ, X’J ‘ì–ç, ŽŒÒ ’¼Ž÷, ’£—ÇŽÀ, •Ÿ‰ÆM“ñ, ‘O“cŠxŽj, •y¼‘ñŽ¡, ’†ˆä—Sˆê˜Y, ‰º‰®_ˆê˜Y, ’†‘º—²•¶
Ä”‚µ‚½LŠÔ–Œ“à‚É”¶‚µ‚½ˆ««“x•s–¾‚Ì•½ŠŠ‹ØŽîá‡iSTUMPj‚ÌÇ—á
‘æ37‰ñ‰ªŽRŽY‰È•wl‰ÈŠw‰ï(‰ªŽR)(2012.11.11)
¬—Ñ ”Ž‹v, •Ÿ‰® ”ü“ÞŽq, ”© žÄ, ŽŒÒ ’¼Ž÷
ƒnƒCƒ_ƒCƒiƒ~ƒbƒNƒŒƒ“ƒW(HDR)‡¬‚É‚æ‚é×–Ef‰æ‘œ‚̉掿‰ü‘P‚ɂ‚¢‚Ä
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(VŠƒ)(2012.11.10)
r–Ø –LŽq, •Ÿ‰® ”ü“ÞŽq, ¬•x ^—, ”© žÄ, ¼‘º LŒ’, ¬’Ë —SŽi, •Û“c _ˆê˜Y, ’†‘º —²•¶, ‰º‰® _ˆê˜Y, X’J ‘ì–ç
”x“]ˆÚ‚ð‚«‚½‚µ‚½—‘‘ƒ«õŽîᇗގ—Žq‹{Žîᇂ̈ê—á
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(VŠƒ)(2012.11.10)
–î”[ Œ¤“ñ, ‘¥¼ —Ç–¾, •½ˆä N•v, Â–Ø ‘å•ã, X’J ‘ì–ç, â–{ –s•F, A“c Žk, ´… ŒbŽq, ’†ŽR —TŽ÷, ¼Œ³ —²
Žq‹{“à–Œ×–Ef‚͑̊à‚Ì‘Šú”Œ©‚É—LŒø‚©?@Žq‹{“à–Œ×–Ef‚Ìf’f¸“xŒüã
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(VŠƒ)(2012.11.9)
X’J ‘ì–ç, ŽŒÒ ’¼Ž÷, ’†‘º —²•¶
Žq‹{“à–Œ×–Ef‚͑̊à‚Ì‘Šú”Œ©‚É—LŒø‚©? ‘Šú‘ÌŠà‚Ì”¶‚Æ•a—‘œ‚Ì“Á’¥
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(VŠƒ)(2012.11.9)
‹{’n ’õK, ŽŒÒ ’¼Ž÷, ‹à ¯“N, –òŽtŽ› G, ‘啽 L, “¡“c ‰ëˆê˜Y, ´… ^ŽŸ˜N, •ŸŒ³ ˜a•F, ŠC•” ŽOŽq, “¡ˆä ’q_, í ‹`, ‰¡ŽR Œõ•F, ‰iˆä “Ö
ìèˆã‰È‘åŠw‚É‚¨‚¯‚é“§ÍtŠàÇ—á‚Ì—Õ°•a—“IŒŸ“¢
‘æ50‰ñ“ú–{ŠàŽ¡—Êw‰ï(‰¡•l)(2012.10.25)
“c’† —[‹IŽq, ²–ì —ÍÆ, X’J ‘ì–ç, ŽŒÒ ’¼Ž÷, Γc „, ’£ —ÇŽÀ, ‘v ”üŒº, •Ÿ‰Æ M“ñ, ‘O“c ŠxŽj, ’†ˆä —Sˆê˜Y, ‰º‰® _ˆê˜Y, ’†‘º —²•¶
’჊ƒXƒNŽq‹{‘ÌŠàpŒã‚É‘lŒaƒŠƒ“ƒpßE–T‘å“®–¬ƒŠƒ“ƒpß“]ˆÚ‚ð‚«‚½‚µ‚½Ç—á
‘æ65‰ñ’†‘Žl‘ŽY‰È•wl‰ÈŠw‰ï(“¿“‡)(2012.9.23)
‘¾“c—T‰î, g—Ñ~ˆê, ¬’r—ǘa, ‰º“oŽu˜N, “¡ˆä´, …“¡»Žq, ŽR–{—T, ’Å–ØŽ —Y, “c’†Ž_, ‰€”ö”ŽŽi, X’J‘ì–ç
“ûŠÇ‘BŽî‚Ì1—á
‘æ9‰ñ“ú–{“ûŠàŠw‰ï’†‘Žl‘’n•û‰ï(o‰_)(2012.9.15)
‰º“oŽu˜N, g—Ñ~ˆê, ŽR‰º“N³, ‰€”ö”ŽŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç
EC followed by docetaxel + doxifluridine p‘O—Ö@‚ÌŽ¡—ÃŒø‰Ê—\‘ªˆöŽq‚Ì•ªÍ
‘æ9‰ñ“ú–{“ûŠàŠw‰ï’†‘Žl‘’n•û‰ï(o‰_)(2012.9.15)
‹àŽq —Ï‹³, ’†‘º M•F, ècŒ´ ŒbŽq, ^“ç ŽŒÈ, m‰È KŽq, ŠF–Ø ƒŽq, â–{ —R”ü, ŒÃì “TŽq, ’|‘º —R•z, ’Øˆä —TŽq, X’J ‘ì–ç, A–Ø G–¾
•a—“÷Šá•W–{Ž©ŒÈŠwKŽx‰‡ƒVƒXƒeƒ€‚ÌŠJ”‚Æ‚»‚Ì‹³ˆçŒø‰Ê‚ÉŠÖ‚·‚錟“¢
‘æ44‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(“Œ‹ž)(2012.7.27)
â–{ —R”ü, ’†‘º M•F, ^“ç ŽŒÈ, m‰È KŽq, ŠF–Ø ƒŽq, ècŒ´ ŒbŽq, ŒÃì “TŽq, ’|‘º —R•z, ’Øˆä —TŽq, ‹àŽq —Ï‹³, X’J ‘ì–ç, A–Ø G–¾
ìèˆã‰È‘åŠwŒ»‘ãˆãŠw‹³ˆç”Ž•¨ŠÙ‚É‚¨‚¯‚鬒†Šw¶‚ð‘ÎÛ‚Æ‚µ‚½ˆãŠw‘ÌŒ±‹³Žº‚ÌŒø‰Ê
‘æ44‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(“Œ‹ž)(2012.7.27)
‹{’n’õK, ŽŒÒ ’¼Ž÷, ‘啽L, “¡“c‰ëˆê˜Y, •ŸŒ³˜a•F, ŠC•”ŽOŽq, “¡ˆä’q_, í‹`, ‰¡ŽRŒõ•F, ‰iˆä“Ö
tŠàŽæˆµ‚¢‹K–ñ‘æ4”Å‚ð—p‚¢‚½tŠàŽèpÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ43‰ñtŠàŒ¤‹†‰ï(“Œ‹ž)(2012.7.22)
²–ì —ÍÆ, Šs ãÄŽu, ‘O“c ŠxŽj, ‰º‰® _ˆê˜Y, X’J ‘ì–ç, ’†‘º —²•¶
pŒã‰»Šw—Ö@’ïR«‚ðŽ¦‚µ‚½Žq‹{‘Ì•”ˆ««ŒŒŠÇŽüˆÍ«—Þã”ç×–EŽî(PEComa)‚̈ê—á
‘æ52‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(“Œ‹ž)(2012.7.19)
ŽŒÒ ’¼Ž÷, g—Ñ ~ˆê, ‰€”ö ”ŽŽi, X’J ‘ì–ç, ´… ç‰ÀŽq, ’Óc ‹Ï, ‹V Œ’“ñ˜Y
Luminalƒ^ƒCƒv‚Ìf’f‚ÆŽ¡—à pŒã•╗Ö@‚Æ‚µ‚Ä’P“Æ“à•ª”å—Ö@‚ðŽó‚¯‚½“ûŠàгŽÒ‚É‚¨‚¯‚é—\ŒãˆöŽq‚̉ðÍ
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.30)
‰º “oŽu˜N, g—Ñ ~ˆê, ŽR‰º “N³, ‰€”ö ”ŽŽi, ŽŒÒ ’¼Ž÷, X’J ‘ì–ç
EC followed by docetaxel+doxifluridinep‘O—Ö@‚ÌŒø‰Ê—\‘ªˆöŽq‚ÌŒŸ“¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.30)
’†ì –õŽm, ’†ì ”ü»Žq, Ⓦ —Ç”ü, ’·”ö –Žq, ‚ˆä ƒ`ƒJŽq, ‘å¼ —²m, –{“c ƒŽq, X’J ‘ì–ç, ò Œ[‰î, ‚‹´ ‰ëŽq, ’O• Í, ù ŽO“¿
Triple Negative“ûŠà(TN“ûŠà)‚É‚¨‚¢‚ÄHER2(0)‚ÍHER2(1+)‚É”ä‚ׂÄBasal-likeŒXŒü‚ª‹‚¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.30)
ŽR‰º “N³, g—Ñ ~ˆê, ‰º “oŽu˜N, ‰€”ö ”ŽŽi, ŽŒÒ ’¼Ž÷, X’J ‘ì–ç
ER—z«“ûŠà‚É‚¨‚¯‚éƒGƒXƒgƒƒQƒ“‚âƒzƒ‹ƒ‚ƒ“—Ö@–ò‚ÌŠàŠ²×–E§Œä‹@\
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.30)
Takuya Moriya, Naoki Kanomata , Yuria Sonan, Kana Namba, Mitsuhiro Hayashi, Takako Imada, Hisashi Hirakawa, Izo Kimijima
Pathological verification of pCR evaluation after preoperative drug therapy.
The 20th Anuual Meeting of The Japanese Breast Cancer Society.(ŒF–{)(2012.6.29)
Mitsuhiro Hayashi, Hiromi Serizawa, Noriko Ootani, Tetsu Tsukamoto, Tetsunari Oyama, Takuya Moriya
Inter-observer variation in Ki67 labeling index.
The 20th Anuual Meeting of The Japanese Breast Cancer Society.(ŒF–{)(2012.6.29)
Yamashita Tetsumasa, Kurebayashi Junichi, Shimo Toshiro, Sonoo Hiroshi, Kanomata Naoki, Moriya Takuya
Characteristics of breast cancer subtypes advocated by the St. Gallen Consensus Conference.
The 20th Anuual Meeting of The Japanese Breast Cancer Society.(ŒF–{)(2012.6.29)
•½ì ‹v, “càV “Ä, ‰ª ‚«‚Ü‚±, –Ø‘º “¹•v, X’J ‘ì–ç, H•Û M•F, ’·“ˆ ^‹I, ˆ¢•Û ¹Ž÷, ŽÀ•û ˆê“T, ˆäŒû ~Žq
“û‘B”S‰t᎗l•a•ςƓûŠà‚Ƃ̊֘A‚ɂ‚¢‚Ă̌Ÿ“¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
Œ“¼ ”üK, –{“c ƒŽq, {Œ© ‚®, ‚‹´ ‰ëŽq, Ⓦ —Ç”ü, X’J ‘ì–ç, ù ŽO“¿
DCIS‚É‚¨‚¯‚éƒTƒuƒ^ƒCƒv•ª—Þ‚Æ•a—‘gDŠw“I“Á’¥‚Ì”äŠrŒŸ“¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
‰¡ˆä ”ÉŽü, ‘O“c _K, ’†àV ‰ëŽq, “¡“c –ƒ“Þ”ü, ¬—û Œ¤Ži, •ÐŽR Š°ŽŸ, ŽRŒû –¾•v, ¡‘º DÍ, X’J ‘ì–ç
“û–[”S‰t«—Þ•\”çŠà‚Ì1—á
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
’†‘º Œc‘¾, —Ñ ŒõO, ¶‹› ŽjŽq, ¼”ö ‘”ü, ŽOâ •‰·, ‹à Œcˆê, ‹ÚàV ”Ž”ü, ‘å’J •ûŽq, X’J ‘ì–ç
—tóŽîᇂÆüˆÛ‘BŽî@ŠÔŽ¿×–E‚Ì«ó‚É’–Ú‚µ‚½ŠÓ•Ê‚ÌŽŽ‚Ý
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
™“c ƒˆê, ˆ¢•” ‰ÀŽq, X’J ‘ì–ç, ù–ì ŒöL
—tóŽîᇂƓûŠÇŠà‚ª¬Ý‚µ‚½‚Ü‚ê‚ÈÇ—á
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
“¡ˆä ´, ‰€”ö ”ŽŽi, ’Å–Ø Ž —Y, âV“¡ ˜i, ¬’r —ǘa, ŽR‰º “N³, ‰º “oŽu˜N, …“¡ »Žq, ŽR–{ —T, ’†“‡ ˆê‹B, “c’† Ž_, g—Ñ ~ˆê, ŽŒÒ ’¼Ž÷, X’J ‘ì–ç
œE“•ª‚ƂƂà‚Ɋକª‚ð‚à”º‚¤ˆ««—tóŽîᇂÌ1—á
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.29)
g—Ñ ~ˆê, ‰º “oŽu˜N, ŽR‰º “N³, ŽŒÒ ’¼Ž÷, X’J ‘ì–ç, ‰€”ö ”ŽŽi
ƒoƒCƒIƒƒW[‚©‚ç‚Ý‚½“ûŠà‚ÌŽ¡—Ãí—ª “ûŠàвזE‚̧Œä‚ðŽw•W‚Æ‚µ‚½V‚µ‚¢Ž¡—Ãí—ª
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
X’J ‘ì–ç, ŽŒÒ ’¼Ž÷
“û‘B•a—f’f‚Ìpitfall ƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpßp’†v‘¬f’f‚Ìpitfall
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
‚‹´ ‰ëŽq, Œ“¼ ”üK, –{“c ƒŽq, Ⓦ —Ç”ü, X’J ‘ì–ç, ù ŽO“¿
ntrinsic subtype•ʂɂ݂½DCIS‰æ‘œŠŒ©
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
ˆÉ“¡ ‹MŽq, ²“¡ –], “càV ’q, ŽRŒû ‚ä‚è, X’J ‘ì–ç, •½ì ‹v, —Ñ Tˆê
ŠàвזE«‚É‚æ‚éLuminalŒ^“ûŠà‚ÌV‚½‚Ȍ•ʉ»
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
²“¡ –], ˆÉ“¡ ‹MŽq, “c’† ”ü•ä, “càV ’q, X’J ‘ì–ç, •½ì ‹v, ŽRŒû ‚ä‚è, —Ñ Tˆê
ƒzƒ‹ƒ‚ƒ“—Ö@‘ϫזE‚ÆŠàŠ²×–E«‚ÌŒŸ“¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
¼”ö ‘”ü, —Ñ ŒõO, ‹ÚàV ”Ž”ü, ‘å’J •ûŽq, ˜e‰® —Î, ’Ë–{ “N, X’J ‘ì–ç, ’†‘º Œc‘¾, ¶‹› ŽjŽq, ‹à Œcˆê, ŽOâ •‰·
“ûŠàƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒp߂ɑ΂·‚éOSNA–@‚ÌŒŸ“¢
‘æ20‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŒF–{)(2012.6.28)
–î”[ Œ¤“ñ, •½ˆä N•v, Â–Ø ‘å•ã, X’J ‘ì–ç, â–{ –s•F
•W–{‚Ì“K³Šî€‚ð‰Á‚¦‚½‹LqŽ®Žq‹{“à–Œ×–Ef•ñ—lŽ®(2012”N”Å)
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2012.6.3)
¬•x ^—, X’J ‘ì–ç, ”© žÄ, ècŒ´ ‘ñ—Y, à_è ŽüŽŸ, ’蕽 ‹g“s
pŒã23”N–Ú‚É”x“]ˆÚ‚𗈂µ‚½—Ç«‘–ŒŽî‚Ì1—á
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2012.6.3)
ècŒ´ ‘ñ—Y, ŽŒÒ ’¼Ž÷, •Ä —º—S, ¬•x ^—, •Ÿ‰® ”ü“ÞŽq, Šs ãÄŽu, ’†‘º —²•¶, ˆÉâX Œ÷, à_è ŽüŽŸ, X’J ‘ì–ç
Žq‹{‚̈««perivascular epithelioid cell tumor(PEComa)‚Ì1—á
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2012.6.3)
H•Û M•F, ’·“ˆ ^‹I, “n•Ó ‚Ý‚©, •½ì ‹v, “càV “Ä, ‰ª ‚«‚ÜŽq, •“c Œ³”Ž, –Ø‘º “¹•v, X’J ‘ì–ç
“û‘BFNAC/CNB“¯ŽžÌŽæ—á‚ÌŒŸ“¢
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2012.6.3)
X’J ‘ì–ç, ŽŒÒ ’¼Ž÷
“ûŠàŽ¡—Âɂ¨‚¯‚é×–Ef’f‚ÌV‚µ‚¢–ðŠ„@”÷¬•a•ςɑ΂·‚é×–Ef’f‚ÌŒ»ó‚Æ–â‘è“_ •a—‚©‚猩‚½”÷¬“û‘B•a•Ï
‘æ53‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(“Œ‹ž)(2012.6.3)
˜[—R‹NŽq, ”©“ñ˜Y, ’|”V“à—zŽq, ’†•ŒbŽq, ’JŒû^—R”ü, Šâˆä”üŠì, ¬“‡Œ’ŽŸ, ˆé“ˆˆËŽq, ‘åŽRˆ¤–¢, ‰Í‡—ljî, ŽŒÒ’¼Ž÷
‘ÌŠOŽ®’´‰¹”g‚ª—L—p‚Å‚ ‚Á‚½äX“à•›äB‚É”¶‚µ‚½epidermoid@cyst‚̈ê—á
‘æ37‰ñ“ú–{’´‰¹”gŒŸ¸Šw‰ï(ŽD–y)(2012.6.2)
X’J ‘ì–ç, X’J —éŽq, “¡Œ´ Œ‰, ŽŒÒ ’¼Ž÷
Žq‹{“à–Œ‚Ì•a—f’f@ŋ߂̒mŒ©‚Æ–â‘è“_ Žq‹{“à–Œ‘BÇE—Þ“à–Œ‘BŠà‚Ƃ̊ӕʂð—v‚·‚éŽq‹{“à–Œ•a•ς̕a—f’f
‘æ101‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2012.4.26)
X’J ‘ì–ç, ŽŒÒ ’¼Ž÷, ‘åˆä ‹±‘ã, â’J ‹MŽi, Œ´“c ‘å, –xˆä —ŠG, ‘O“c ˆê˜Y, ŽRŒû —Ï, •½ì ‹v
ƒo[ƒ`ƒƒƒ‹‰æ‘œ‚ð—p‚¢‚½“û‘Bj¶ŒŸ•a—ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚̸“x
‘æ101‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2012.4.26)
¼‘º —ƒ, ’–ŽR Œ«ˆê, ›–ì —SK, •£ Œ°, ”’Î ‘׎O, ŒÃ’J ŒhŽO, X’J ‘ì–ç, ‹gŒ© ’¼ŒÈ, “n•Ó ‚Ý‚©, –ì“c —T, àVˆä ‚Žu
ƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒh‚ð—p‚¢‚½‘‡“IŠwKƒc[ƒ‹‚ÌŠJ”
‘æ101‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2012.4.26)
ŽŒÒ’¼Ž÷
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu“ûŠà‚Ì•a—
‘æ28‰ñ“ú–{“û‘Bbó‘B’´‰¹”gf’f‰ï‹c(‰ªŽR)(2012.4.22)
ŽŒÒ’¼Ž÷
“û‘B޾г‚Ì•a—
‘æ28‰ñ“ú–{“û‘Bbó‘B’´‰¹”gf’f‰ï‹c(‰ªŽR)(2012.4.22)
ŽŒÒ’¼Ž÷AX’J‘ì–ç
t×–EŠà‚É‚¨‚¯‚évasohibin”Œ»‚ÉŠÖ‚·‚é–Æ‰u‘gDŠw“IŒŸ“¢
‘æ7‰ñVasohibinŒ¤‹†‰ï(å‘ä)(2012.2.20)
Miyaji Y, Kanomata N, Ohira S, Obatake A, Fujita M, Fukumoto K, Fujii T, Jo Y, Yokoyama T and Nagai A
Use of Fuhrman grading system for Japanese patients with renal cell carcinoma
ASCO-GU i2012 Genitourinary Cancers Symposiumj (San Francisco USA)(2012.2.4)
X’J‘ì–ç
“û‘Bj¶ŒŸ‚Ì•a—f’f
IAP“ú–{Žx•”2011”NƒXƒ‰ƒCƒhƒZƒ~ƒi[(“Œ‹ž)(2011.11.19)
ŽŒÒ’¼Ž÷, ²“¡–õŽj, ‹{’n’õK, ‰iˆä“Ö, X’J‘ì–ç
t×–EŠà‚É‚¨‚¯‚錌ŠÇ‘BE—}§ˆöŽq‚Ì”Œ»‚ÉŠÖ‚·‚é–Æ‰u‘gDŠw“IŒŸ“¢
‘æ57‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2011.11.17)
Hinamoto N, Maeshima Y, Saito D, Yamasaki H, Nasu T, Watatani H, Ujike H, Kinomura M, Kitamura S, Sugiyama H, Kanomata N, Sonoda H, Sato Y and Makino H
Immunohistochemical analysis of Vasohibin-1 using renal biopsy specimens of patients with renal disorders
American Society of Nephrology Meeting(Philadelphia, Pennsylvania, USA )(2011.11.10)
‰º“oŽu˜N, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç, ‰€”ö”ŽŽi
“û‘B PARP‘jŠQ–òAZD2281‚Ì“ûŠà×–E‚ɑ΂·‚éRŽîᇌø‰Ê
‘æ49‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(–¼ŒÃ‰®)(2011.10.27)
’J–{‘åŒá, “Œ_Ž÷, ŽR–{—º, ‹Ê“c•×, ˆÉ“ŒŽ”\, X’J‘ì–ç
–Iâ|”x‚ɇ•¹‚µ‚½”xG•½ã”çŠà‚Ì1—á@CPFE(combined pulmonary fibrosis and emphysema)‚ÌŠT”O‚Ƃ̊֌W‚ðŠÜ‚ß‚Ä
‘æ47‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï(‰ºŠÖ)(2011.10.23)
–î”[Œ¤“ñ, •½ˆäN•v, –ؑå•ã, X’J‘ì–ç, â–{–s•F
‰·ŒÌ’mV!‚±‚ê‚©‚ç‚Ì“à–Œ×–Ef Žq‹{“à–Œ×–Ef‚ÌŠ´“xE“ÁˆÙ“x‹y‚Ñ‹LqŽ®“à–Œ×–Ef•ñ—lŽ®
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.23)
•Ä—º—S, •Ÿ‰®”ü“ÞŽq, r–Ø–LŽq, ¬•x^—, ¬—Ñ”Ž‹v, ècŒ´‘ñ—Y, ”©žÄ, ’蕽‹g“s, ŽŒÒ’¼Ž÷
cŠuŽîᇂɂ¨‚¯‚éCTƒKƒCƒh‰º¶ŒŸŽž‚̃xƒbƒgƒTƒCƒh×–Ef‚Ì—L—p«
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.22)
’·“ˆ^‹I, •½ì‹v, H•ÛM•F, –Ø‘º“¹•v, “n•Ó‚Ý‚©, X’J‘ì–ç
“û‘B•½’RŒ^ˆÙŒ^(Flat epithelial atypia)•a‘ƒ‚Ì×–EŠw“IŒŸ“¢
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.22)
ŠsãÄŽu, X’J‘ì–ç, ˆÉâXŒ÷, •Ÿ‰®”ü“ÞŽq, r–Ø–LŽq, Šâ’m“¹L‹v, ²–ì—ÍÆ, ’ª“cŽŠ‰›, ’†‘º—²•¶
4”NŠÔ‚̃tƒHƒ[ƒAƒbƒv‚ʼnŠú‚ÌŽq‹{èò•”“àèò•”Œ^”S‰t«‘BŠà‚ðf’f‚µ“¾‚½Ç—á
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.22)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“û‘B×–Ef‚ÌV‚½‚È“WŠJ@‘‰Á‚·‚鑊úŠà‚Ìf’f —Lj«ŠÓ•Ê¢“ïŽ¾Š³‚Ì×–E‘œ
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.22)
•Ÿ‰®”ü“ÞŽq, ”©žÄ, ècŒ´‘ñ—Y, ¬—Ñ”Ž‹v, ¬•x^—, •Ä—º—S, r–Ø–LŽq, ŽŒÒ’¼Ž÷, X’J‘ì–ç, ’蕽‹g“s
Female expert workshop@×–Ef’f‚ÉŒg‚í‚é—«‚ÌA˜J‚ÆŒ¤‹†ŠÂ‹«ƒTƒ|[ƒg‚ðl‚¦‚é ‘åŠw•a‰@×–EŒŸ¸Žm‚Æ‚µ‚Ă̕à‚݂ƉªŽR×–EŒŸ¸Žm‚ð‘ÎÛ‚Æ‚µ‚½ƒAƒ“ƒP[ƒg’²¸‚̂܂Ƃß
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(“Œ‹ž)(2011.10.22)
Miyaji Y, Kanomata N, Ohira S, Tsukimori S, Fukumoto K, Hara R, Fujii T, Jo Y, Yokoyama T, Nagai A
Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients
31st Societe Internationale D'Urologie : SIU(Berlin, Germany)(2011.10.17)
ˆÉ“¡‹MŽqC“càV’qCŽRŒû‚ä‚èC“c’†”ü•äC²“¡–]CX’J‘ì–çC•½ì‹vC—ÑTˆê
“ûŠà‘gD•ª—£×–E‚ÌŠàŠ²×–E«‚ÌŒŸ“¢‚Æintrinsic subtype‚Æ‚Ì‘ŠŠÖ
‘æ70‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï(–¼ŒÃ‰®)(2011.10.4)
²–ì—ÍÆ, ŠsãÄŽu, X’J‘ì–ç, ŽŒÒ’¼Ž÷, Γc„, ‘O“cŠxŽj, ’£—ÇŽÀ, ’ª“cŽŠ‰›, ’†ˆä—Sˆê˜Y, ‰º‰®_ˆê˜Y, ’†‘º—²•¶
p‘Of’f‚ª¢“ï‚Å‚ ‚Á‚½—‘‘ƒŒ´”‘B‹ØŽî‚̈ê—á
‘æ64‰ñ’†‘Žl‘ŽY‰È•wl‰ÈŠw‰ï(•ÄŽq)(2011.9.17)
•½ì‹vC–Ø‘º“¹•vCX’J‘ì–ç, “càV“ÄCH•ÛM•FC’·“ˆ^‹ICˆ¢•Û¹Ž÷CŽÀ•ûˆê“T
“û‘B•a•Ï‚Ìf’f‚É×–Ef‚Æj¶ŒŸ‚𓯎žŽ{s‚µ‚½Ç—á‚ÌŒŸ“¢
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.3)
“càV“ÄC•½ì‹v, –Ø‘º“¹•vCX’J‘ì–çCˆ¢•Û¹Ž÷CŽÀ•ûˆê“T
“–‰@‚ł̃}ƒ“ƒ‚ƒg[ƒ€¶ŒŸ‚É‚æ‚蔌©‚³‚ꂽMucocele-like lesionÇ—á‚ÌŒŸ“¢
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.3)
‚–Ø´Ži, X’J‘ì–çC•Z¹ŽjC‰ª‚«‚ÜŽqC–L“‡—²C•ˆäаKC•½ì‹v, ΓcFéC g—Ñ~ˆêC—ÑTˆêC ŽO–ØNG, ù–ìŒöLC—é–Ø‹M
’jŽq“ûŠà‚É‚¨‚¯‚éƒGƒXƒgƒƒQƒ“ì—p
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.3)
ˆÉ“¡‹MŽq, “càV’q, ‰Ô‘º“OC“c’†”ü•äCŽRŒû‚ä‚è, X’J‘ì–ç, •½ì‹v, —ÑTˆê
“ûŠà‘gD•ª—£×–E‚ÌŠàŠ²×–E«‚ÌŒŸ“¢‚Æ—Õ°•a—Šw“IˆöŽq‚Æ‚Ì‘ŠŠÖ
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.3)
”ò“c—z, ˆä㔎“¹CŽÂŒ´‹±ŽqC‚‹´ˆè—Y, X’J‘ì–ç, …–ì—m•ã,‘åé—R”ü
PASH‚𔺂¤hamartoma‚̈ê—á‚Æ—Ç«Žîá‡57—á‚Æ‚Ì”äŠr
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.2)
g—Ñ~ˆêCŽŒÒ’¼Ž÷CX’J‘ì–çC‰º“oŽu˜NC¬’Ë—SŽiC‰€”ö”ŽŽi
“ûŠà‚ÌŽ•ž‚ð–ÚŽw‚µ‚½–ò•¨—Ö@F“ûŠàвזE‚ðŽw•W‚Æ‚µ‚½Šî‘bŒ¤‹†
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.2)
‰º“oŽu˜NCg—Ñ~ˆêCŽŒÒ’¼Ž÷C¬’Ë—SŽiCX’J‘ì–çC‰€”ö”ŽŽi
“ûŠà×–E‚ɑ΂·‚éPARP‘jŠQ–òAZD2281‚ÌRŽîᇌø‰Ê‚ÉŠÖ‚·‚éŠî‘bŒ¤‹†
‘æ19‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(å‘ä)(2011.9.2)
”©žÄCŽOã–FŠìCŽŒÒ’¼Ž÷CX’J‘ì–ç
•a—‘gD‘œ‚ðŠî”Õ‚Æ‚µ‚½ˆÝŒ^”S‰t‚ð—L‚·‚éŽq‹{èò•”‘BŒn•a•ς̌©•û‚Æ‘¨‚¦•û
‘æ26‰ñ“ú–{—Õ°×–EŠw‰ï’†‘Žl‘˜A‡‰ï‘‰ïEŠwpW‰ï(“¿“‡)(2011.7.31)
’·Ž¡½, ‰Í‡´“ú, ˆÉŒ´’¼”ü, ´…Œ’Ž¡, ¬—ÑŒv‘¾, X’J‘ì–ç
Ö¬“à•½ŠŠ‹ØŽîÇ(Intravenous leiomyomatosis)‚Ì1—á
‘æ50‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(ŽD–y)(2011.7.22)
‘O“cŠxŽj, ²–ì—ÍÆ, ŠsãÄŽu, X’J‘ì–ç, ŽŒÒ’¼Ž÷, Γc„, ’£—ÇŽÀ, ’ª“cŽŠ‰›, ’†ˆä—Sˆê˜Y, ‰º‰®_ˆê˜Y, ’†‘º—²•¶
“÷Žî‚Ƃ̊ӕʂª¢“ï‚Å‚ ‚Á‚½”ñí‚É‹H‚È—‘‘ƒ‘B‹ØŽî‚̈ê—á
‘æ50‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(ŽD–y)(2011.7.22)
‰º“oŽu˜N, “c’†Ž_, âV“¡˜i, ‘¾“c—T‰î, “¡ˆä´, …“¡»Žq, ŠÖ^—, ŽR–{—T, ’†“‡ˆê‹B, g—Ñ~ˆê, ‰€”ö”ŽŽi, à_èŽüŽŸ, X’J‘ì–ç
‘½”œ“]ˆÚ‚ðŒ_‹@‚É”Œ©‚³‚ꂽ”÷¬ZŒ^bó‘Bàh–EŠà‚̈ê—á
‘æ23‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï(“Œ‹ž)(2011.7.7)
ŽŒÒ’¼Ž÷
p‘O–ò•¨Ž¡—Â̕a—Šw“IŒø‰Ê”»’è
‘æ5‰ñ“ûŠà•a—f’fƒZƒ~ƒi[(‰ªŽR)(2011.6.30)
ŽŒÒ’¼Ž÷C¬’Ë—SŽiCX’J‘ì–ç
äNã÷•a•Ï
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ïi‘æ105‰ñƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒXj(ì)(2011.6.25)
‹v–{WŽq, •ĉԗL, ‚“cˆê˜Y, ŠÛì«b, –쑺’·‹v, X’J‘ì–ç
¶–³‹C”x‚ɂĔ»–¾‚µ‚½“ûŠàpŒãÄ”‚Ì1—á
‘æ34‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹¾Šw‰ïŠwpW‰ï(•l¼)(2011.6.16)
—Œ³‹I˜a, ‘O“‡—m•½, Ö“¡‘å•ã, ŽRè_Žq, –È’J”Žá, ™ŽRÄ, ŽŒÒ’¼Ž÷, ‰€“cŒõ, ²“¡–õŽj, ê –ì”ŽŽj
t޾ггŽÒ‚É‚¨‚¯‚錌ŠÇV¶§ŒäˆöŽqVasohibin-1‚Ì”Œ»•ω»‚Æ‚»‚Ì—Õ°“IˆÓ‹`‚ɂ‚¢‚Ă̌Ÿ“¢
‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï(‰¡•l)(2011.6.16)
r–Ø–LŽqC•Ÿ‰®”ü“ÞŽqC¬—Ñ”Ž‹vCècŒ´‘ñ—YC”©žÄC‘å‘qvCŽŒÒ’¼Ž÷C¼‘ºLŒ’Cà_ú±ŽüŽŸC’蕽‹g“s
ƒxƒbƒgƒTƒCƒh×–Ef‚ª—LŒø‚Å‚ ‚Á‚½–j•”Žîᎌ`¬«‹}«œ‘«”’ŒŒ•a‚̈ê—á
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(•Ÿ‰ª)(2011.5.22)
”©žÄCr–Ø–LŽqC•Ä—º—SC¡–ì˜aŽ¡C¬•x^—C•Ÿ‰®”ü“ÞŽqC¬—Ñ”Ž‹vC¬’Ë—SŽiCŽŒÒ’¼Ž÷CX’J‘ì–ç
“û‘BúŽh‹zˆø×–Ef‚É‚¨‚¯‚éLBC–@‚Æ]—ˆ–@‚Ì‘Šˆá“_‚È‚ç‚тɖâ‘è“_‚ɂ‚¢‚Ä
‘æ52‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(•Ÿ‰ª)(2011.5.22)
¬—ѳ‘ãC‹g“c½C“잊”ŽC‚‹´³lCŽŒÒ’¼Ž÷CX’J‘ì–çC‘“cO‹B
¸‘ƒã‘Ìclear cell adenocarcinoma‚̈ê—á
‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï(‰¡•l)(2011.4.28)
¬—ÑŒv‘¾CX’J‘ì–ç
Œã• –Œ‚ÉŽîᎌ`¬‚ð”F‚ß‚½ŒŒŠÇ“àiÖ¬“àj•½ŠŠ‹ØŽîÇIntravenous(Intravascular)leiomyomatosis‚Ì‚P—á
‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï(‰¡•l)(2011.4.28)
ŒF–ØLŽ}C”~‘º‚µ‚Ì‚ÔC¼‘º—ŒbŽqCŽŒÒ’¼Ž÷C÷ˆäF‹KC‹VŒ’“ñ˜YC’Óc‹Ï
“ûŠà‘gD‚̃zƒ‹ƒ‚ƒ“Žó—e‘̂ɂ‚¢‚Ă̎©“®‰æ‘œ‰ðÍ‘•’u‚ð—p‚¢‚½‘½Ž{Ý‹¦“¯Œ¤‹†
‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï(‰¡•l)(2011.4.28)
X’J‘ì–çCX’J—éŽqC“¡Œ´Œ‰C¬’Ë—SŽiCŽŒÒ’¼Ž÷
Žq‹{“à–Œ‘BÇE—Þ“à–Œ‘BŠà‚Ƃ̊ӕʂð—v‚·‚éŽq‹{“à–Œ•a•ς̕a—f’f
‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï(‰¡•l)(2011.4.28)
X’J‘ì–çC‘哇FˆêC¡‘ºDÍC”ª”ö—²ŽjCò”ü‹MCª–{‘¥“¹
ƒAƒ“ƒP[ƒg’²¸‚©‚ç‚Ý‚½•a—ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚ÌŽÀî
‘æ100‰ñ“ú–{•a—Šw‰ï‘‰ï(‰¡•l)(2011.4.28)
–Ø‘º‰À‹N, ¼–{Œ[Žu, ‘åàVŒ³•Û, ŒE“cŽõŽq, ‰Yã~, ‘½“c‘å˜a, ‹g“c_Ži, X’J‘ì–ç, ¬’Ë—SŽi, ‚…Œ¤ˆê, Š™“c’q—L, ‰–’JºŽq, ”©“ñ˜Y, tŠÔŒ«
“–‰@‚ÅŒoŒ±‚µ‚½\“ñŽw’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ì2—á
‘æ‚V‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï(‹ž“s)(2011.2.18)
ŽŒÒ’¼Ž÷
‚ª‚ñ‚ÆŠÔŽ¿‘ŠŒÝì—p
‘æ198‰ñìèˆãŠw‰ïu‰‰‰ï(‘q•~)(2011.2.4)
¼”ö—EŽ™, “c‘ã_“¿, •ПºG—², –öˆäL”V, X’J‘ì–ç
ƒGƒ“ƒhƒƒgƒŠƒI[ƒVƒX‚Æ—‘‘ƒŠà —‘‘ƒ–¾×–E‘BŠà‚Ì•a—‘gDŠw“IŒŸ“¢@–¾×–E‘BŠà‚Í’Pˆê‚Ì”Íáe‚Å‚‚‚ç‚ê‚é‚Ì‚©?
‘æ32‰ñ“ú–{ƒGƒ“ƒhƒƒgƒŠƒI[ƒVƒXŠw‰ï(“Œ‹ž)(2011.1.22)
X’J‘ì–ç
“û‘Bj¶ŒŸ‚Ì•a—f’f
‘æ50‰ñ•a—Šw‹³ˆçƒZƒ~ƒi[(•Ÿ‰ª)(2010.11.27)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“û‘B×–Ef’f‚±‚Ƃ͂¶‚ß “ûŠà“ÁŽêŒ^‚ÌŠŒ©‚Æ•ñ“à—e
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(_ŒË)(2010.11.21)
ŠsãÄŽu, X’J‘ì–ç, ŽŒÒ’¼Ž÷, ècŒ´‘ñ—Y, •Ÿ‰®”ü“ÞŽq, Šâ’m“¹L‹v, ’†‘º—²•¶
Žq‹{“à–Œ×–Ef‚ðŒ_‹@‚É”Œ©‚³‚ꂽŽq‹{“à–ŒŸ÷‰t«ã”ç“à‘BŠà‚̈ê—á
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(_ŒË)(2010.11.21)
¬—Ñ”Ž‹v, ¡–ì˜aŽ¡, •Ÿ‰®”ü“ÞŽq, ”©žÄ, X’J‘ì–ç
ƒtƒŠ[ƒ\ƒtƒg‚ð—p‚¢‚½×–Ef‰æ‘œ‚É‚¨‚¯‚é—§‘Ì‘œ¶¬‚ÌŽŽ‚Ý
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(_ŒË)(2010.11.21)
“càV“Ä, •½ì‹v, –Ø‘º“¹•v, X’J‘ì–ç, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
ƒXƒeƒŒƒIƒKƒCƒh‰ºƒ}ƒ“ƒ‚ƒg[ƒ€¶ŒŸ‚ÅŠÓ•Ê¢“ï‚Æf’f‚³‚ꂽǗá‚ÌŒŸ“¢
‘æ20‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï(•Ÿ‰ª)(2010.11.19)
¡“cFŽq, ‰€”ö”ŽŽi, X’J‘ì–ç
ãüâ|‹ß‚‚ÉoŒ»‚µ‚Äf’f‚ÉŽžŠÔ‚ð—v‚µ‚½Z«¬—tŠà‚Ì1—á
‘æ20‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï(•Ÿ‰ª)(2010.11.19)
ŽŒÒ’¼Ž÷
“ûŠà‚É‚¨‚¯‚éHER2•a—”»’è‚ɂ‚¢‚Ä
HER2 Pathological Seminar(‰ªŽR)(2010.11.5)
g—Ñ~ˆê, ‰€”ö”ŽŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç, Œ´“c·‹`, ìè—RŽq, “c‘º–Îs, ’cˆêK, ‹eì‹IO, ’†ŽR’q, ŽÄŽR³Ž÷, ÎŒ´‰pв, –ìŒûáÁŽO˜Y
RB‚ð•W“I‚Æ‚µ‚½‰ä‚ª‘”‚ÌV‹K•ªŽqf’f‹y‚Ñ•ªŽq•W“I–ò‚ÌŠJ” pŒã•╉»Šw—Ö@‚ðŽó‚¯‚½“ûŠàгŽÒ‚É‚¨‚¯‚éC2PŒŸ¸‚Ì—\Œã—\‘ªˆöŽq‚Æ‚µ‚Ă̗L—p«
‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(‹ž“s)(2010.10.28)
‰º“oŽu˜N, g—Ñ~ˆê, ‰€”ö”ŽŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç, ¬’Ë—TŽi
pŒã•╃zƒ‹ƒ‚ƒ“’P“ƗÖ@‚ðŽó‚¯‚½“ûŠàгŽÒ‚É‚¨‚¯‚é—\ŒãˆöŽq‚̉ðÍ
‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(‹ž“s)(2010.10.28)
‰ª•ü‘åC“¡–{‘s”ªC”–츔VC“¡–{–õ˜YC“J–ØF–¾C–x‰Æ‰p”VC\‘qŒ’•FC‹îˆä‘¥•vC¬’Ë—SŽi,•y“c“Þ—¯–çC²X–ØŠÂC”Œ´’¼Ž÷
RŽ_‹…‘‘½Ç‚ðŒ_‹@‚É”Œ©‚³‚ꂽ”A׊NJԎ¿«t‰Š‚̈ê—á
‘æ59‰ñ‰ªŽRt޾г§˜b‰ï(‰ªŽR)(2010.10.2)
“¡ˆä´, ‰€”ö”ŽŽi, ’Å–ØŽ —Y, âV“¡˜i, ‘¾“c—T‰î,ŽR‰º“N³, ‰º“oŽu˜N, …“¡»Žq, ŠÖ^—, ŽR–{—T, ’†“‡ˆê‹B, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç
’jŽq“ûŠà‚Ì‚Q—á
‘æ‚V‰ñ“ú–{“ûŠàŠw‰ï’†‘EŽl‘’n•û‰ï(‚’m)(2010.9.25)
‰ª‚«‚ÜŽq,X’J‘ì–ç,•Z¹Žj,‚–Ø´Ži,ŽO–ØNG,–L“‡—²,•ˆäаK,•½ì‹v, ΓcFé,g—Ñ~ˆê,—ÑTˆê,ù–ìŒöL,—é–Ø‹M
’jŽq“ûŠà‚É‚¨‚¯‚髃zƒ‹ƒ‚ƒ“Žó—e‘̂̔Œ»
‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï(‘åã)(2010.9.24)
ˆÉ“¡‹MŽq, “càV’q, ŽRŒû‚ä‚è, “c’†”ü•ä,X’J‘ì–ç, •½ì‹v, —ÑTˆê
“ûŠàŒ´”Žîᇂɂ¨‚©‚éŠàвזE‚̉ðÍ
‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï(‘åã)(2010.9.23)
Sakae Hata,Naoki Kanomata,Toshiaki Kamei,Takuya Moriya
Collagenous stroma in body fluid cytology -Characteristic features and clinicopathological significance-
The 10th International Conference of the International Mesothelioma Interest Group(‹ž“s)(2010.9.2)
Takuya MORIYA
The ‚athological features of breast carcinoma in Asian women
‘æ9‰ñƒAƒWƒA—Õ°Žîᇊw‰ïEŠwpW‰ï(Šò•Œ)(2010.8.26)
’Óc‹Ï,“y‰®áÁˆê,”~‘º‚µ‚Ì‚Ô,HŽR‘¾,X’J‘ì–ç
‘æ2‰ñ“û‘B•a—f’fŒ¤‹†‰ïƒZƒ~ƒi[@•a—ˆã•Ò
‘æ2‰ñ“û‘B•a—f’fŒ¤‹†‰ïƒZƒ~ƒi[(“Œ‹ž)(2010.8.8)
ècŒ´ŒbŽq, â–{—R”ü, ’†‘ºM•F, ŠF–؃Žq, ^“玌È, X’J‘ì–ç, A–ØG–¾
Ž÷މ•ï–„•W–{‚Ì‹³ˆç“IŠˆ—p–@‚ÉŠÖ‚·‚錟“¢
‘æ42‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(“Œ‹ž)(2010.7.31)
’†‘ºM•F, ècŒ´ŒbŽq, m‰ÈKŽq, Ž›‰ª˜a”ü, ’|‘º—R•z, ŒÃì“TŽq, X’J‘ì–ç, A–ØG–¾
ƒ‚ƒoƒCƒ‹PC‚ð—˜—p‚µ‚½•a—“÷Šá•W–{Ž©ŒÈŠwKŽx‰‡ƒVƒXƒeƒ€‚ÌŽŽì
‘æ42‰ñ“ú–{ˆãŠw‹³ˆçŠw‰ï‘å‰ï(“Œ‹ž)(2010.7.30)
‚–ìŽu, ™ŽR“O, ”ªdŠ~L¶, ‰F“cìN”Ž, ’Óc_Žj, —é–ØŒõ–¾, ’|“à‘, ’Óc‹Ï, X’J‘ì–ç, ‹e’r‹`Œö
—‘‘ƒ–¾×–E‘BŠà‘Šú—á‚ɑ΂·‚鉉ñ‰»Šw—Ö@@Japan Clear Cell Carcinoma StudyŒã•ûŽ‹“IŒŸ“¢
‘æ48‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(’}”g)(2010.7.8)
ŠsãÄŽu, X’J‘ì–ç, ’ª“cŽŠ‰›, ²–ì—ÍÆ, Γc„, ’£—ÇŽÀ, ’†ˆä—Sˆê˜Y, ‰º‰®_ˆê˜Y, ’†‘º—²•¶
Žq‹{“à–ŒŸ÷‰t«ã”ç“à‘BŠà‚É‚¨‚¢‚ÄA•a•Ï‚ªŽq‹{èò•”‚ɂ܂ÅL‚ª‚胊ƒ“ƒpß“]ˆÚ‚ªŽw“E‚³‚ꂽˆê—á
‘æ48‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpu‰‰‰ï(’}”g)(2010.7.8)
´Œ´”ŽŽj, •½ì‹v, –Ø‘º“¹•v, X’J‘ì–ç, “càV“Ä, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
“ûŠàpŒã”x“]ˆÚ‚ɑ΂·‚éŠO‰È“IŽ¡—ÃÇ—á‚ÌŒŸ“¢
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
ŠÖ^—, “c’†Ž_, Ö“¡˜i, ‘¾“c—T‰î, “¡ˆä´, ‰º“oŽu˜N, …“¡»Žq, ŽR–{—T, ’Å–ØŽ —Y, ’†“‡ˆê‹B, g—Ñ~ˆê, ‰€”ö”ŽŽi, •Ÿ‰®”ü“ÞŽq, X’J‘ì–ç
Žîᇓà[ǂ𔺂Á‚½“û–[ŽîᎂÌ2—á
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, g—Ñ~ˆê, ‰€”ö”ŽŽi, X’J‘ì–ç
Z«¬—tŠàf’f‚É‚¨‚¯‚éƒJƒeƒjƒ“–ƉuõF‚Ì—L—p«‚ÌŒŸ“¢
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
•½ì‹v, “càV“Ä, –Ø‘º“¹•v, X’J‘ì–ç, ´Œ´”ŽŽj, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
ƒrƒmƒŒƒ‹ƒrƒ“‚ð2”NˆÈã‚Ì’·Šú‚ɓЗ^Œp‘±’†‚ÌisÄ”“ûŠà7Ç—á‚ÌŒŸ“¢
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
“¡ˆä´, ‰€”ö”ŽŽi, ’Å–ØŽ —Y, âV“¡˜i, ‘¾“c—T‰î, ‰º“oŽu˜N, …“¡»Žq, ŠÖ^—, ŽR–{—T, ’†“‡ˆê‹B, “c’†Ž_, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç
”A˜H•ÂÇ‚ð‚«‚½‚µ‚½“ûŠàŒã• –Œ“]ˆÚ‚Ì3—á
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
Œ´“c‘å, “y‰®áÁˆê, HŽR‘¾, X’J‘ì–ç, ’Óc‹Ï, ”~‘º‚µ‚Ì‚Ô, –xˆä—Œb, ŽRŒû—Ï, ‘O“cˆê˜Y, ŽŒÒ’¼Ž÷, ¬’Ë—SŽi
“û‘B‚Ì×–Ef‚Æj¶ŒŸ‚ÌŒ»ó‚Æ–â‘è“_ j¶ŒŸEƒ}ƒ“ƒ‚ƒg[ƒ€¶ŒŸ‚É‚¨‚¯‚é•a—f’f‚ÌŒ»ó‚Æ–â‘è“_@“û‘Bj¶ŒŸf’fuK‰ï‚ÌŒ‹‰Ê‚©‚ç
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
‰º“oŽu˜N, g—Ñ~ˆê, ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç, ‰€”ö”ŽŽi
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu“ûŠà‚ɑ΂·‚éV‹K–ò•¨—Ö@‚ÌŠî‘bŒ¤‹†
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.25)
‹g“cˆê–ç, ŒN“‡ˆÉ‘¢, ‚–ö”Žs, X’J‘ì–ç
p‘O•a—f’f‚É‚¨‚¢‚Ä×–Ef‚Í‚»‚Ì’nˆÊ‚ðˆÛނł«‚é‚©
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
ŠC£”ŽŽj, ‘å–ì^Ži, ‘呺“Œ¶, ˆÉ“¡—Ç‘¥, Šâ£‘ñŽm, Š}Œ´‹`˜Y, ‹e’n–ƒ”ü, ŒN“‡ˆÉ‘¢, –Ø‘º¹”ü, •ΗDŽq, “c’†Š®Ž™, ‹Ê‹´—eŽq, ’·£Žœ‘º, ¼‰YçŒbŽq, ¼“cŽõ”üŽq, ‹{—Ç‹…ˆê˜Y, X’J‘ì–ç, –xŒû~, ‰à•xŽm—Y
–¾“ú‚ð‘ñ‚“û‘Bê–åˆã‚Æ“ûŠàƒ`[ƒ€ˆã—ÂÌÝ‚è•û ŽÐ‰ï‚Ì–Úü‚©‚çl‚¦‚éƒ`[ƒ€ˆã—Â̎À‘H@With You@‚ ‚È‚½‚ƃuƒŒƒXƒgƒPƒA‚ðl‚¦‚é‰ï
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
ˆê–{™‘, ›Á“NŸ«, ‘å•lŽõ”Ž, ‰ª‘º‘וF, ¼–ØN^, X’J‘ì–ç
’j«“û–[è÷—±–Œ×–EŽî‚Ì1—á
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
ˆÉ“¡‹MŽq, “càV’q, ŽRŒû‚ä‚è, X’J‘ì–ç, •½ì‹v, —ÑTˆê
“ûŠà‘gD‚©‚ç‚ÌŠàŠ²×–E‚Ì“¯’èE”|—{‚ÌŽŽ‚Ý‚Æ—Õ°•a—Šw“IˆöŽq‚Æ‚Ì‘ŠŠÖ
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
ŽŒÒ’¼Ž÷, g—Ñ~ˆê, ¬’Ë—SŽi, ‰€”ö”ŽŽi, X’J‘ì–ç
“ûŠà‚É‚¨‚¯‚éSrc”Œ»‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
X’J‘ì–ç ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, •½ì‹v, “càV“Ä, –Ø‘º“¹•v, ŒN“‡ˆÉ‘¢, g—Ñ~ˆê, ‰€”ö”ŽŽi
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒuŒ^DCIS‚Ì•a—Šw“I“Á’¥
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
Šâ“cLŽ¡,ìŒû‰pr,²Ž¡dt,’†ŽR‹Mа,Œüˆä”Ž•¶,X’J‘ì–ç,Norway@Jurgen Geisler
ƒzƒ‹ƒ‚ƒ“—z«“ûŠà‚ÉpŒã‰»Šw—Ö@‚Í•K—v‚©H?–¢—ˆ‚ðŒ©˜‚¦‚Ä–{‰¹‚ÅŒê‚é?
‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(ŽD–y)(2010.6.24)
X’J‘ì–ç
“û‘B‘gDŒ^„’è‚ÌŒÀŠEFj¶ŒŸ‚ł̕a—f’f
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
r–Ø–LŽq, ¡–ì˜aŽ¡, •Ÿ‰®”ü“ÞŽq, ”©žÄ, ¼‘ºLŒ’, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, ˆÉâXŒ÷, ’蕽‹g“s, à_èŽüŽŸ
Žq‹{“à–ŒÞ—¿‚É“ûŠà—R—ˆ‚ٌ̈^×–E‚ª”F‚ß‚ç‚ꂽ1—á@Ž©Œ±—á‚Æ•¶Œ£“IlŽ@
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
¡–ì˜aŽ¡, ¬’Ë—SŽi, r–Ø–LŽq, ”©žÄ, ècŒ´‘ñ—Y, Šâ’m“¹L‹v, ŽŒÒ’¼Ž÷, X’J‘ì–ç
–Í‹[úŽh‹zˆø×–Ef‚É‚¨‚¯‚éE-Cadherin‰A«“ûŠà‚Ì×–E‘œ‚ÌŒŸ“¢
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
–î”[Œ¤“ñ, •½ˆäN•v, –ؑå•ã, X’J‘ì–ç, â–{–s•F
‹LqŽ®•ñ—lŽ®‚ð—p‚¢‚½Žq‹{“à–Œ×–Ef‚ÌŠ´“x“ÁˆÙ“xŠm—§‚ÆŒüã‚Ì‚½‚߂̑½Ž{Ý‹¤“¯Œ¤‹†
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
”©žÄ,X’J‘ì–ç
”ñZ«“ûŠÇŠàiDCIS)‚Ì×–E‘œ‚ɂ‚¢‚Ä
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
ŽŒÒ’¼Ž÷,”©žÄ,¬’Ë—SŽi,X’J‘ì–ç
×–Ef‚É‚æ‚é“ÁŽêŒ^“ûŠà‚Ì‘gDŒ^„’è
‘æ51‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(‰¡•l)(2010.5.31)
X’J‘ì–ç, •Ÿ‰®”ü“ÞŽq
ƒxƒZƒXƒ_ƒVƒXƒeƒ€‚É”—‚é Žq‹{èò•”×–Ef@V•ñ—lŽ®“±“ü‚̈Ӌ`
‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2010.4.29)
ŽR–{@•½, Š}“‡“ÖŽq, “‡è‰pK, ‚–ìŽu, X’J‘ì–ç, ’Óc‹Ï, ¼Œ´C
—‘‘ƒŽîᇂ̊î‘b‚Æ—Õ°@–¾×–E‘BŠà‚Ì•a—‘œA•a‘Ô‰ðÍ‚»‚µ‚ÄŽ¡—ÂÌÅ‘Oü –¾×–E‘BŠà‚̈««“x•ª—Þ
‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2010.4.29)
X’J‘ì–ç, ’†‘ºM•F, ècŒ´ŒbŽq, A–ØG–¾
ˆãŠw‹³ˆç‚É‚¨‚¯‚éƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒh‚ÌŠˆ—p ƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒhƒVƒXƒeƒ€‚ð—p‚¢‚½•a—Šw‹³ˆç@ˆãŠw‹³ˆç”Ž•¨ŠÙ‚É‚¨‚¯‚éŒoŒ±
‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2010.4.28)
•£Œ°, ŽO‰YNG, ‹gŒ©’¼ŒÈ, ’–ŽRŒ«ˆê, X’J‘ì–ç, ”’Α׎O, “n•Ó‚Ý‚©, ¼–ì‹gG, àVˆä‚Žu
ƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒh‚ð—˜—p‚µ‚½ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒVƒXƒeƒ€‚ÌŠm—§
‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2010.4.28)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“ûŠà–ò•¨—Ö@‚Ì‚½‚߂̕a—f’f‚Ì–â‘è“_ “ûŠà–ò•¨—Ö@‚Ì‚½‚߂̕a—f’f‚Ì–â‘è“_A“Á‚ÉERAPgRAHER2”»’è‚ÉŠÖ‚µ‚Ä
‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï(“Œ‹ž)(2010.4.28)
“càV“Ä, •½ì‹v, ´Œ´”ŽŽj, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T, –Ø‘º“¹•v, X’J‘ì–ç
ΊD‰»•a•ςɑ΂·‚é“–‰@‚̃}ƒ“ƒ‚ƒg[ƒ€¶ŒŸ
‘æ7‰ñ“ú–{“ûŠàŠw‰ï“Œ–k’n•û‰ï(å‘ä)(2010.3.6)
“J–ØF–¾C–x‰Æ‰p”VC¬—ÑLÆC“¡–{‘s”ªC\‘qŒ’•FC‹îˆä‘¥•vC•y“c“Þ—¯–çC²X–ØŠÂC”Œ´’¼Ž÷C•£_ŽjC‹{‰ºCsCŽŒÒ’¼Ž÷CHŽR—²
‹¹–Œˆ««’†”çŽî‚ð”¶‚µ‚½ˆÛŽ“§ÍгŽÒ‚̈ê—á
‘æ88‰ñ‰ªŽR“§Í§˜b‰ï(‰ªŽR)(2009.11.28)
”–¹ŽqC‹g“c_ŽiC‰Í£’qÆC•xŽR‹±sCm‰È‘yŽ¡C‹g‰ª“Þ•äŽqCŒ´—TˆêC¥‰iŒ\ŽqC¥‰i‹§ÐCŽŒÒ’¼Ž÷C‰Yã~CX’J‘ì–çC•½ˆä•qOC“ú–ìŒ[•ã
GIST‚âäXŽîᇂƂ̊ӕʂð—v‚µ‚½_ŒoâŽî‚̈ê—á
‘æ92‰ñ“ú–{Á‰»Ší•aŠw‰ï’†‘Žx•”—á‰ï(L“‡)(2009.11.28)
¬•x^—CècŒ´‘ñ—YC”©žÄ, “¡ˆä’q‹vCà_ú±ŽüŽŸC’蕽‹g“sCX’J‘ì–ç
”AŠÇŒ´”“à”½Œ^”A˜Hã”çŠà‚Ì2—á
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2009.10.31)
X’J‘ì–ç, ¼Œ´”üK
“û‘B×–Ef‚É‚¨‚¯‚éŠÓ•Ê¢“ï—á‚Ì×–E‘œ‚Ǝ戵‚¢ “û‘B×–Ef‚É‚¨‚¯‚éŠÓ•Ê¢“ï‹æ•ªÝ’è‚̈Ӌ`
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2009.10.31)
¡–ì‚©‚¨‚è, ŽO‰YOŽç, ’·“ˆ^‹I, H•ÛM•F, “n•Ó‚Ý‚©, X’J‘ì–ç
“û‘B×–Ef‚É‚¨‚¯‚éŠÓ•Ê¢“ï—á‚Ì×–E‘œ‚Ǝ戵‚¢ yŠÓ•Ê¢“ïzÇ—á‚ÌŽÀÛ
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2009.10.31)
”©žÄ, ŽŒÒ’¼Ž÷, X’J‘ì–ç, ‚{‰ê”Ž‹v, •¨•”‘×¹
މ–b“÷Žî—l¬•ª‚𔺂¤—tóŽîá‡
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï(•Ÿ‰ª)(2009.10.30)
ŠÛ”ö—z•½C‹Ê錤‘¾˜NCX’J‘ì–çC‚‹´–í¶C²“¡–õŽjC•½ì‹vC‹ÊéMŒõCΓcFéC‘å“àŒ›–¾Cù–ìŒöL
ƒqƒg“ûŠà‚É‚¨‚¯‚éVasohibin-1”Œ»‚ÌŒŸ“¢
‘æ68‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.10.2)
‹gì–M•F, ‘]ªÆŠì, X’J‘ì–ç, ‰iˆä´‹v, ŽO‘º_˜N, •Ÿ‰im•v
Š{œ‰óŽ€‚ÌFDG-PET@•a—ŠŒ©‚Ƃ̔äŠr
‘æ49‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï(ˆ®ì)(2009.10.2)
²–ì—ÍÆ, ’ª“cŽŠ‰›, Ž›“‡—R‰À—, Γc„, ’£—ÇŽÀ, ’ª“c‚Ü‚èŽq, ’†‘º—²•¶, X’J‘ì–ç, ŽRŒû‰À”V, ‰º‰®_ˆê˜Y
”ç—l”X–EŽî‚ɇ•¹‚µ‚½—‘‘ƒŒ´”ŒŒŠÇ“÷Žî‚̈ê—á
‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï-’†‘Žl‘‡“¯’n•û•”‰ï‘‰ï(•ÄŽq)(2009.9.27)
X’J‘ì–çC •ПºG—²
—‘‘ƒŽîᇂɑ΂·‚é–Æ‰u‘gD‰»Šw‚Ì—L—p«@Œ»ó‚Æ“W–]
‘æ47‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï(‰¡•l)(2009.9.22)
X–{¹Žq, ‹g“c_Ži, ‘½“c‘å˜a, –쑺‰ÀŽ, ‰Í£’qÆ, ²“¡‰ë, ’·“c—S‹P, Ζì~, ‹”öƒ, Œ´—Tˆê, ‹{“c‰pŽ÷, ‰Yã~, ŽŒÒ’¼Ž÷, Šâ”ö”NN, “ú–ìŒ[•ã, ²“¡ˆêO
L”͈͕\‘wi“W‚ª‚Ý‚ç‚ꂽ•½’RZŒ^’_ŠÇŠÇó‘BŠà‚̈ê—á
‘æ44‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï(–¼ŒÃ‰®)(2009.9.19)
“¡ˆä´C‰€”ö”ŽŽiC’Å–ØŽ —Y, âV“¡Š¢C‘¾“c—T‰î, ‰º“oŽu˜N, ŽO‘q, ŠÖ^—, ŽR–{—T, ’†“‡ˆê‹B, “c’†Ž_, g—Ñ~ˆê, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷C X’J‘ì–ç
Žá”N”ǂ̓û‘B‘B—l”X–EŠà‚Ì‚P—á
‘æ6‰ñ“ú–{“ûŠàŠw‰ï’†‘Žl‘’n•û‰ï(‰ªŽR)(2009.9.5)
—é–Ø‹MA‚–Ø´ŽiCŽO–ØNGCX’J‘ì–çC‘å“àŒ›–¾Cù–ìŒöL
“ûŠà‚É‚¨‚¯‚髃zƒ‹ƒ‚ƒ“‹ÇЇ¬
‘æ41‰ñ“ú–{—Õ°•ªŽqŒ`‘ÔŠwŠw‰ï‘‰ïEŠwpW‰ï(_ŒË)(2009.9.4)
“¡‘º‹IsA‰€•”GCŠCŒ´‹±ŽqC‰HŒ´—˜KCX’J‘ì–ç
“û‘BZ«”÷¬“û“ªŠà‚ƊŽY¶Šà‚Ì×–E‘œ‚Æ—Õ°•a—
‘æ24‰ñ“ú–{—Õ°×–EŠw‰ï’†‘Žl‘˜A‡‰ïŠwpW‰ï(‰ªŽR)(2009.7.10)
X’J‘ì–çC¬’Ë—SŽi, ŽŒÒ’¼Ž÷
“û‘B޾г‚ÌŠÓ•Êf’f‚É‚¨‚¯‚é–Æ‰u‘gD‰»Šw‚Ì—L—p«
‘æ24‰ñ“ú–{—Õ°×–EŠw‰ï’†‘Žl‘˜A‡‰ïŠwpW‰ï(‰ªŽR)(2009.7.10)
X’J‘ì–ç, ¬’Ë—SŽi, •Ÿ–{Šî, ŽŒÒ’¼Ž÷
DCIS‚ÌŠî‘b‚Æ—Õ° DCIS‚ÆŽü•Ó•a•ς̕a—
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, ”’Α׎O, X’J‘ì–ç
‰ß¬E‰ßèf’f‚Ɋׂè‚â‚·‚¢“û‘B•a•Ï@Œ»ó‚Æ‘Îô “û‘B޾г‚̗Lj««ŠÓ•ʂɂ¨‚¯‚é–Æ‰uõF‚ÌŒ»ó‚Ɖۑè
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
Œ´“c‘å, “y‰®áÁˆê, HŽR‘¾, X’J‘ì–ç, ’Óc‹Ï, ”~‘º‚µ‚Ì‚Ô
“û‘Bj¶ŒŸ•S—á‚Ì•a—ê–åˆã14–¼ŠÔ‚Å‚Ìf’fˆê’v—¦‚ÌŒŸ“¢
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
X’J‘ì–ç, •½ì‹v, “càV“Ä, Γc˜a”V, “n•Ó‚Ý‚©, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, –Ø‘º“¹•v
Z«“ûŠà‚É‚¨‚¯‚étopoisomerase IIƒ¿‚Ì”Œ»‚ÉŠÖ‚·‚é–Æ‰u‘gDŠw“IŒŸ“¢
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
•½ì‹v, –Ø‘º“¹•v, X’J‘ì–ç, “càV“Ä, H•ÛM•F, ’·“ˆ^‹I, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
”S‰t᎗lŽîᇂɇ•¹‚µ‚½”ñZŠà14Ç—á‚ÌŒŸ“¢
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
ÎŒ´ßŽq, •Љª³•¶, ¼ŽR‹XF, –Ø‘ºGK, X’J‘ì–ç
2”NŠÔ‰æ‘œã•ω»‚ªŒ©‚ç‚ꂸA“ûŠà‚ªŒŸo‚³‚ꂽspiculated mass‚Ì1—á@‰æ‘œŠŒ©‚ð’†S‚É
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
ŠÛŽR——¯Œh, r–؈Ÿšæ, ”‘q³K, ŽO¬‘PŒõ, ¼Œ’, ˆî”ö“µŽq, •S—¯”üŽ÷, X’J‘ì–ç
—«‰»“û–[‚ðƒx[ƒX‚É”¶‚µAŠ®‘SØœ‚ɋꗶ‚µ‚½’j«DCIS‚Ì1—á
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
Έ䕑Žq, ŒN“‡ˆÉ‘¢, —é–Ø^•F, ŽR“c—²”V, X’J‘ì–ç
—Ç«“û“ªó•a•Ï‚ÌMRIf’f‚ÉŠÖ‚·‚錟“¢
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
“càV“Ä •½ì‹v, –Ø‘º“¹•v, X’J‘ì–ç, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
ãüâ|‚É”¶‚µ‚½‹ÇŠis“ûŠà‚̈ê—á
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
•½”ö—Ç”Í ”ª–Ø‹´M•v, ‘åàV’‰Ž¡, ‚‹´½Ži, ŒI“c•², ΓcFé, —é–Øº•F, ‹Ê錤‘¾˜N, “n•Ó‚Ý‚©, X’J‘ì–ç
‹zˆøŽ®‘gD¶ŒŸ‚Åflat epithelial atypia‚ÌŠŒ©‚ð’æ‚µ‚½1—á
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
‰º“oŽu˜N, ‘¾“c—T‰î, “¡ˆä´, ŽO‘q, ŠÖ^—, ‘y“c–ƒˆß, –쑺’·‹v, ŽR–{—T, ’Å–ØŽ —Y, ’r“c‰ë•F, ’†“‡ˆê‹B, “c’†Ž_, g—Ñ~ˆê, ‰€”ö”ŽŽi, X’J‘ì–ç
“û‘BƒAƒ|ƒNƒŠƒ“Šà10—á‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
–k‘º³•q, Šp“c—Í–í, X’J‘ì–ç
“û‘BŠà“÷Žî‚Ì1—á
‘æ17‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï(‰¡•l)(2009.7.3)
¬—Ñ”Ž‹vCŠâ’m“¹L‹vC•Ÿ‰®”ü“ÞŽqC”©žÄCX’J‘ì–ç
ƒtƒŠ[ƒ\ƒtƒg‚É‚æ‚é×–Ef‚É‚¨‚¯‚éÅ“_‡¬‰æ‘œ‚Ì”äŠr
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.28)
•Ÿ‰®”ü“ÞŽqCˆÉâXŒ÷Cà_ú±ŽüŽŸC’·“ˆ^‹ICH•ÛM•FCXŽR•üŽqCâV“¡—R‹NŽqCˆÀ’B—F’ÃCŽO‰YOŽçCX’J‘ì–ç
“û‘BúŽh‹zˆø×–Ef‚É‚¨‚¯‚錟‘Ì•s“K³‚Ì—vˆö‚ÉŠÖ‚·‚錟“¢
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.28)
X’J‘ì–ç,ŽŒÒ’¼Ž÷C¬’Ë—SŽiC’†‘º—²•¶C‰º‰®_ˆê˜Y
Žq‹{“à–Œ•a•ς̕a—‘gDf’f‚Æ×–Ef’f‚É‚¨‚¯‚鑊ˆá‚ÌŒ´ˆöF•a—‘gDf’f‚Ì—§ê‚©‚ç
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.28)
¡–ì‚©‚¨‚èCŽO‰YOŽçC“n•Ó‚Ý‚©C—é–Ø‹MC‰HŒ´—˜KC“¡‘º‹IsCX’J‹±ŽqC‹½‰Æ‹v“¹C‰ÍŒ´“c®CX’J‘ì–ç
ŒûoG•½ã”çŠà‚Ì×–E‘œ‚Æ‚»‚ÌŒXŒü‚ɂ‚¢‚Ă̌Ÿ“¢
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.27)
¬’Ë—SŽiCŽŒÒ’¼Ž÷CŠâ’m“¹L‹vC¡–ì˜aŽ¡CX’J‘ì–ç
“–‰@‚É‚¨‚¯‚éZ«¬—tŠà×–Ef‚ÌŒŸ“¢
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.27)
ìè•ü”ÍC¬ŽR•q—YCŒ´mCΈäŒb—C’†ì”ü‹IC’†àV‹v”üŽqCΈä‘P—YC‹|”[Ž•×CX’J‘ì–ç,‰Á“¡—Ç•½
Myoepitheliosis‚ɇ•¹‚µ‚½ƒAƒ|ƒNƒŠƒ“Œ^”ñZ«“ûŠÇŠà
‘æ50‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïitŠú‘å‰ïj(“Œ‹ž)(2009.6.27)
ŽŒÒ’¼Ž÷C¬’Ë—SŽiC–쑺’·‹vCX’J‘ì–ç
“û‘BŽîá‡
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ï(‘æ99‰ñƒXƒ‰ƒCƒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX)(‚’m)(2009.6.13)
¬’Ë—SŽiC ŽŒÒ’¼Ž÷C“ú‰º•”“C ¯ƒTƒ†ƒŠC‘å’| “OCX’J‘ì–ç
—¼‘¤“û‘BŽîáŽ
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ï(‘æ99‰ñƒXƒ‰ƒCƒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX)(‚’m)(2009.6.13)
X’J‘ì–ç
“û‘Bj¶ŒŸ-•a—f’f‚Ì“Á’¥‚Æpitfall
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ï(‘æ99‰ñƒXƒ‰ƒCƒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX)(‚’m)(2009.6.13)
‚‹´‰ëM, ŒÃì—mˆê, ‰º•½GŽ÷, ŽðŠñ^l, X’J‘ì–ç, X’J‹Xá©, ‹g“c‹P•F, ‹àŽqãà, ’†‘º—S•ã, Ήªç‰ÁŽj
MLH1 intron 9‚Ìsplice donor site‚ɕψقð”F‚ß‚½HNPCC‚Ìˆê‰ÆŒn
‘æ15‰ñ“ú–{‰Æ‘°«Žîᇊw‰ïŠwpW‰ï(“Œ‹ž)(2009.6.12)
ŽŒÒ’¼Ž÷
t‘Ÿtubulocystic carcinoma‚̈ê—á
‘æ98 ‰ñ“ú–{•a—Šw‰ï‘‰ï(‹ž“s)(2009.5.3)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, •Ÿ–{Šî, Γc˜a”V, “n•Ó‚Ý‚©, X’J‘ì–ç
“¯‘¤“û–[‚Ɉٌ^¬—t‰ßŒ`¬‚𔺂¤“ûŠà‚Ì—Õ°•a—Šw“I“Á’¥
‘æ98 ‰ñ“ú–{•a—Šw‰ï‘‰ï(‹ž“s)(2009.5.3)
X’J‘ì–ç
ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“‚Ì•W€Žè‹Z‚ƃsƒbƒgƒtƒH[ƒ‹@@•a—‚Ì—§ê‚©‚ç
‘æ22‰ñ“ú–{“û‘Bbó‘B’´‰¹”gf’f‰ï‹c(“Œ‹ž)(2009.4.26)
—é–ØçD, ¼“‡M‰À, ‘O“c³K, ’|“cа, ‚‘ºŒõK, ¬’Ë—SŽi, “’“cŒúŽi
”ñ“TŒ^“I‚ÈMRIŠŒ©‚ð’æ‚µ‚½¬Ž™èò•”މ–b‰èŽî‚Ì1—á
‘æ69‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï(‰¡•l)(2009.4.8)
—é–ØçD, ¼“‡M‰À, ‘O“c³K, ’|“cа, ¼Œ´”N¶, ¬’Ë—SŽi
Melanotic neuroectodermal tumor of infancy‚Ì1—á
‘æ69‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï(‰¡•l)(2009.4.8j
ŽŒÒ’¼Ž÷, X’J‘ì–ç
t×–EŠà‚Å‚Ìvasohibin–Ɖu‘gDŠw“IŒŸ“¢
‘æ4‰ñVasohibinŒ¤‹†‰ï(å‘ä)(2009.3.17)
¬’Ë—SŽi
“dŽq“Š•[‚É‚æ‚éGleason•ª—Þ‚ÌŽÀ‘H
‘æ12‰ñ“ú–{•a—Šw‰ï’†•”Žx•”ƒXƒ‰ƒCƒhƒZƒ~ƒi[(’Ã)(2009.3.14)
T Kiyokawa, T Moriya, H Ishikura(Deceased), SG Silverberg
Reproducibility of Histological Diagnosis of Ovarian Clear Cell Adenocarcinoma.
98th Annual Meeting, Unitied States and Canadian Academy of Pathology (Boston)(2009.3.7)
X’J‘ì–ç, –öˆäL”V
•a—Ǘጟ“¢
‘æ2‰ñ“ûŠà•a—f’fƒZƒ~ƒi[(‰ªŽR)(2009.2.26)
X’J‘ì–ç
“ûŠÇ“à•a•Ï‚ð‚ß‚®‚é”–â‘èFV‚µ‚¢Ž¾Š³ŠT”OE•´‚ç‚킵‚¢Ž¾Š³
‘æ15‰ñ“ú–{“û‘B޾гŒ¤‹†‰ï(•Ÿ“‡)(2009.2.14)
ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç,ŽðˆäNK
tŽîá‡
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ï (‘æ98‰ñƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒX)(¼ŽR)(2009.2.14)
X’J‘ì–ç
ˆ««‚ƊԈႢ‚â‚·‚¢—Ç«“û‘B޾г‚Ì•a—‚Æ×–E‘œ
‘æ29‰ñ“ú–{—Õ°×–EŠw‰ï–kŠC“¹Žx•”‘‰ï‚È‚ç‚тɊwpW‰ï(ŽD–y)(2008.11.16)
”©žÄ, X’J‘ì–ç
×–EfƒZƒ~ƒi[@’†•_ŒoŒn‚Ìp’†v‘¬×–Ef@oŒ»ƒpƒ^[ƒ“‚©‚ç‚Ý‚½×–Ef’fŠw“IƒAƒvƒ[ƒ`‚ɂ‚¢‚Ä
‘æ47‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï(“Œ‹ž)(2008.11.15)
X’J‘ì–ç
HER2•a—f’f‚ÌŽÀÛ
‘æ47‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï(“Œ‹ž)(2008.11.15)
X’J‹±Žq, ‰€•”G, “¡‘º‹Is, ‰HŒ´—˜K, ²“¡³˜a, 켂Ȃ݋I, ”©žÄ, X’J‘ì–ç, ‹Tˆä•qº
• –Œ“§Í‚É‚¨‚¯‚锽‰ž«’†”ç‚Ì×–EŠw“I“Á’¥‚ɂ‚¢‚Ä
‘æ47‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï(“Œ‹ž)(2008.11.14)
’·“ˆ^‹I, ŽŒÒ’¼Ž÷, ŽO‰YOŽç, ¬’Ë—SŽi, “n•Ó‚Ý‚©, H•ÛM•F, “càV“Ä, •½ì‹v, –Ø‘º“¹•v, X’J‘ì–ç
‰ßèE‰ß¬”»’è‚Ɋׂè‚â‚·‚¢“û‘B‚Ì×–E‘œ‚Æ‚»‚Ì—Õ°@‚ǂ̂悤‚ÈŠŒ©‚ð‚ǂ̂悤‚Éf’f‚·‚é‚Ì‚©? ”S‰t᎗lŽîᇂÌ×–E‘œ@ˆ««“x„’è‚̉”\«‚Æ‚»‚̈Ӌ`‚ÉŠÖ‚·‚錟“¢
‘æ47‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï(“Œ‹ž)(2008.11.14)
¬’Ë—SŽi, ŽŒÒ’¼Ž÷, Γc„,’†‘º—²•¶,X’J‘ì–ç
Žq‹{Žîá‡
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”ŠwpW‰ï ‘æ97‰ñƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒX(L“‡)(2008.11.8)
]ìVˆê, ’Ë–{M˜a, Γc»Œº, ˆ¢•”‰i, —Ñ—m‹B, Ô“c¹‹I, Œ³ˆä“~•F, •Њñ—F, Γc˜a”V, X’J‘ì–ç, –xˆä–¾, ŠC–ì—Ï–¾
äXŠà‚É‚¨‚¯‚éWT1”Œ»
‘æ67‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï(–¼ŒÃ‰®)(2008.10.29)
‰Á‰ê’J‘D, ‰œŽR—²•½, ‘Šêß–ç, ‘å‰Í“à‹œŽq, ’£‘ÖG˜Y, X’J‘ì–ç, ˆê”——æ
“ÁˆÙ]‚ª‚Ý‚ç‚ꂽCastleman's disease‚Ì1—á
‘æ70‰ñ“ú–{”畆‰ÈŠw‰ï“Œ•”Žx•”Šwp‘å‰ï(O‘O)(2008.10.14)
ŽŒÒ’¼Ž÷, ¬’Ë—SŽi, X’J‘ì–ç
“û‘B•a•Ï
‘æ196‰ñ‰ªŽRŠO‰È•a—Œ¤‹†‰ï(‰ªŽR)(2008.10.10)
X’J‘ì–ç
“ûŠà‚Ì”¶‚Æi“W‚ÉŠÖ‚·‚镪ŽqŒ`‘ÔŠw“IƒAƒvƒ[ƒ`
‘æ40‰ñ“ú–{—Õ°•ªŽqŒ`‘ÔŠw‰ï(•Ÿ‰ª)(2008.10.3)
“càV“Ä, •½ì‹v, –Ø‘º“¹•v,X’J‘ì–ç, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
ƒn[ƒZƒvƒ`ƒ““Š—^‚ɂăAƒiƒtƒBƒ‰ƒLƒV[‚ð‹N‚±‚µCƒiƒxƒ‹ƒrƒ“+ƒ[ƒ[ƒ^“Š—^‚ɂĒ·ŠúPR‚Å‚ ‚é”x“]ˆÚ‚̈êÇ—á
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
¬’Ë—SŽi, X’J‘ì–ç, HŽR‘¾, •Z¹Žj, Gary M Tse, Puay-Hoon Tan, ŽŒÒ’¼Ž÷, ‘å“àŒ›–¾, g—Ñ~ˆê, ‰€”ö”ŽŽi
“ûŠà‚Ì‘gDŒ^•ª•zFƒAƒWƒA‚É‚¨‚¯‚é‘Û”äŠr
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
‹Ê錤‘¾˜N, ù–ìŒöL, ΓcFé, ‘å“àŒ›–¾, X’J‘ì–ç
V‚µ‚¢ŒŒŠÇV¶—}§ˆöŽq(vasohibin)‚Ì“û‘B޾г‚É‚¨‚¯‚錟“¢‚Æ“ûŠà•W“IŽ¡—Âւ̓W–]
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
‘Žq‚³‚‚«, ‚‹´M, ΓcFé, ‘å“àŒ›–¾, X’J‘ì–ç, ù–ìŒöL, –ì…®, Špì—zˆê˜Y, Ήªç‰ÁŽj
Multiplex RT-PCR–@‚ð—p‚¢‚½“ûŠà—\Œã—\‘ªˆâ“`Žqf’f‚ÌŠJ” ‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
X’J‘ì–ç, “n•Ó‚Ý‚©, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, •½ì‹v, –Ø‘º“¹•v, ΓcFé, ‘å“àŒ›–¾, g—Ñ~ˆê, ‰€”ö”ŽŽi
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒuiTNj“ûŠà‚Ì•a—‘gDŠw“I“Á«‚ÉŠÖ‚·‚錟“¢
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
g—Ñ~ˆê, X’J‘ì–ç, ‰€”ö”ŽŽi
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒu“ûŠà‚Ì–ò•¨—Ö@‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.27)
‚‹´—T, “c’†—², ‹g—Ç”ü»Žq, X–{’‰‹», X’J‘ì–ç
“ûŠÇ“à“û“ªŽî‚Ƃ̊ӕʂª¢“ï‚Å‚ ‚Á‚½Solid papillary carcinoma‚Ì1—á
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.26)
•½ì‹v, “càV“Ä, –Ø‘º“¹•v, X’J‘ì–ç, H•ÛM•F, ’·“ˆ^‹I, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T
‹‘åŽîᎂðŒ`¬‚µ‚½‘B‹Øã”çŽî‚Ì‚P—á
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.26)
ˆê–{™‘, “NŸ«, ‘å•lŽõ”Ž, ‰ª‘º‘וF, X’J‘ì–ç, ¼–ØN^
“÷‰èŽî«“û‘B‰Š‚Ì6—á
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.26)
Šp“c”ŽŽq, —LLŒõŽi, ˆé–{ˆê˜Y, ‘åŠÑK“ñ, ¬’Ë—SŽi, Œ~‰ªŒ‹‰ê, “‡“c—FK, ‰º‰ª‰ØŽq, —é–Øº•F, “Œ–ì‰p—˜Žq, ŒËèŒõG, “¡Œõ—¥Žq, –xˆä—ŠG, ‘O“cˆê˜Y, X’J‘ì–ç
“ûŠàf—ÃKƒCƒhƒ‰ƒCƒ“2008”N‰ü’ù‚Ìà–¾@ŒŸfEf’f
‘æ16‰ñ“ú–{“ûŠàŠw‰ï‘‰ï(‘åã)(2008.9.26)
Kanomata N
Slide conference, case T-5
The 2nd Japanese-Taiwan Conjoint Slide Conference (•Ÿ‰ª)(2008.9.6)
“c’†—¹, ¼”ö–¾Žq, “¡–{˜j, X’J‘ì–ç
“û“ª•”Invasive Micropapillary Carcinoma‚Ì1’j«—á
‘æ24‰ñ“ú–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ï(Šò•Œ)(2008.8.7)
X’J‘ì–ç, ¼‘ºLŒš, ’ª“cŽŠ‰›, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, HŽR—², ’†‘º—²•¶, ‰º‰®_ˆê˜Y
G•½ã”ç”í•¢«”X–E‚ð•t‚µ‚½—‘‘ƒŒŒŠÇ“÷Žî‚Ì‚P—á
‘æ44‰ñ“ú–{•wl‰ÈŽîᇊw‰ïŠwpW‰ï(–¼ŒÃ‰®)(2008.7.17)
¬’Ë—SŽi
bó‘BŽîᇂ̈ê—á
‘æ195‰ñ‰ªŽRŠO‰È•a—Œ¤‹†‰ï(‰ªŽR)(2008.7.11)
X’J‘ì–ç
“ûŠÇ“à•a•ς̕a—‚Æ×–E‘œFŋ߂̒mŒ©‚àŠÜ‚ß‚Ä
‘æ28‰ñ“ú–{—Õ°×–EŠw‰ï‰ªŽRŽx•”‰ï(‰ªŽR)(2008.7.5)
”©žÄ, •Ÿ‰®”ü“ÞŽq, ŽŒÒ’¼Ž÷, X’J‘ì–ç
“û‘B‚ÌúŽh‹zˆø×–Ef‚Å‘B—l”X–EŠà‚ÆŠÓ•Ê‚ð—v‚µ‚½mucinous spherulosis‚ð—L‚·‚é“û‘Bǂ̂P—á
‘æ28‰ñ“ú–{—Õ°×–EŠw‰ï‰ªŽRŽx•”‰ï(‰ªŽR)(2008.7.5)
‹gì–M•F, ‘]ªÆŠì, ˜a“cG•ä, ’蕽‹g“s, X’J‘ì–ç, ²–ìŽj“T, ¼‹´‰ÀŽq, ‰iˆä´‹v, ŽO‘º_˜N, •Ÿ‰im•v
”’ŒŒ•a‚ÌFDG-PRT
‘æ43‰ñ“ú–{ŠjˆãŠw‰ï’†Žl‘’n•û‰ï(o‰_)(2008.6.28)
ŽŒÒ’¼Ž÷, ˆÉâX Œ÷, ¬’Ë—SŽi, í ‹`, X’J‘ì–ç
tŽîá‡
“ú–{•a—Šw‰ï’†‘Žl‘Žx•”‰ïŠwpW‰ï (‘æ96‰ñƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒŒƒ“ƒX)(o‰_)(2008.6.28)
X’J‘ì–ç, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷
ƒzƒ‹ƒ‚ƒ“Žó—e‘ÌŒŸ¸‚Ì‚½‚߂̓K؂ȌŸ‘̈—‚Æ•]‰¿–@
‘æ20‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï(å‘ä)(2008.6.12)
X’J‘ì–ç
Žq‹{èò•”×–Ef‚É‚¨‚¯‚éƒxƒZƒXƒ_ƒVƒXƒeƒ€“±“ü‚̈Ӌ`[•a—ˆã‚Ì—§ê‚©‚ç[
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
‰HŒ´—˜K, ‰€•”G, X’J‹±Žq, “¡‘º‹Is, ޳ŒË–¾”ü, ”©žÄ, X’J‘ì–ç, ¬’rGŽ¢, ‹Tˆä•qº
• …’†‚ÉoŒ»‚·‚锽‰ž«’†”ç‚Æ”wŒi•a•Ï
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
X’J‘ì–ç, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, Šâ’m“¹L‹v, ”©žÄ, ŽO‰YOŽç, “n•Ó‚Ý‚©
–Ɖu‘gD‰»Šw‚Í“û‘B޾г‚̗Lj««ŠÓ•ʂɖ𗧂‚©
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
”©žÄ, •Ÿ‰®”ü“ÞŽq, X’J‘ì–ç
“û‘B×–Ef‚É‚¨‚¯‚édiagnostic clue[“ûŠÇ“à“û“ªŽî‚Ì”»’è‚É–ð—§‚Â×–EŠŒ©
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
‘¥¼—Ç–¾, X’J‘ì–ç, ‹{–{•üK, ŽO‘îN”V, ‘å–ì‰pŽ¡
PTEN,ƒÀ[ƒJƒeƒjƒ“,p53‚É‚¨‚¯‚é—Ç«Žq‹{“à–Œ‚ł̖Ɖu×–E‰»Šw“I”Œ»
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
“¡‘º‹Is, ‰€•”G, X’J‹±Žq, ‰HŒ´—˜K, X’J‘ì–ç
“û‘Bè÷—±×–EŽî‚̈ê—á
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.8)
–î”[Œ¤“ñ, •½ˆäN•v, –ؑå•ã, X’J‘ì–ç, â–{–s•F
‹LqŽ®•ñ—lŽ®‚ð—p‚¢‚½Žq‹{“à–Œ×–Ef[\‘z‚©‚玎Œ±‰^—p‚Ü‚Å[
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.7)
X’J‘ì–ç
“û‚ª‚ñ@‘gD‚Æ×–E‘œ@“û‘B޾г‚Ì‘gD•ª—Þ‚Æ×–E‘œ[ŋ߂̓®Œü‚©‚ç[
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.7)
”©žÄ, •Ÿ‰®”ü“ÞŽq, X’J‘ì–ç
Šî’ê×–E—l“ûŠà‚Ì•a—‘gDE×–EŠw“I“Á’¥‚ɂ‚¢‚Ä
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.7)
‘å–ì‰pŽ¡, ‘¥¼—Ç–¾, ´…ŒbŽq, ’ÉÎR’©ç, ÷ˆäF‹K, X’J‘ì–ç,–{‹½~Ži, âŒû‘ì–ç, r•”ª‹N,ŽO‘îN”V, ‹{–{•üK, •šŒ©ãĈê˜Y
–³¸—‘«ŽüŠú‚É”º‚¤ƒzƒ‹ƒ‚ƒ“•s‹Ït“à–Œ‚Ì‘gD‘œE×–E‘œ‚Æ‚»‚̈â“`“IŒŸõ
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.7)
ŽŒÒ’¼Ž÷
ƒo[ƒ`ƒƒƒ‹ƒXƒ‰ƒCƒhƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX@‚Ü‚ê‚ÈŽîá‡C‹«ŠE•a•ÏCˆ««‘BŽî‚È‚Ç@“û‘B
‘æ49‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï(tŠú‘å‰ï)(“Œ‹ž)(2008.6.7)
X’J‘ì–ç
HER2—z«“ûŠà‚Ì•a—f’f‚ÆV‚½‚ÈpŒã•╗Ö@‚Ì“WŠJ
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.17)
‘å“¡‚Žu, X’J‘ì–ç, ŽO‹´’qŽq, Žá‹·Ž¡‹B
‘æ96‰ñ‘‰ï•ñu‰ñ’°úE‚Å”»–¾‚µ‚½’´‚—îŽÒ‚̬’°ƒNƒ[ƒ“•a‚Ƭ’°ƒzƒWƒLƒ“•a‚̇•¹—áv‚»‚ÌŒã
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.17)
‹Êì‹óŽ÷, ŽR–{—zˆê˜N, ŠÈ–ì’¼Žq, X’J‘ì–ç, •Ÿ–{Šw
‚—îŽÒ‚É‚¨‚¯‚é”x—Þã”猌ŠÇ“à”çŽî‚Ì‚Q—á
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.17)
²X–Ø‹B, X’J‘ì–ç, ‰Í“à], ‘ºã‚ ‚ä‚Ý, –ìàVº“T
“ûŠà×–EfE‘gDf’f‚É‚¨‚¯‚éŠO‰Èˆã‚Æ•a—ˆã‚ÌŒ©‰ð‚̈Ⴂ[ƒAƒ“ƒP[ƒgŒ‹‰Ê‚ÉŠî‚¢‚Ä[
97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.16)
Œ´“c—SŽ¡, ‹g“cŠw, ŠÛŽR——¯Œh, •À‰Í“O, X’J‘ì–ç
Adenoid cystic carcinoma—ÞŽ—‚Ì‘œ‚ð’æ‚µ‚½Z«“ûŠÇŠà‚Ì‚P—á
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.16)
Lì‰ÀŽj, “n•Ó¹r, “à“cŽ“T, ¬’Ë—SŽi, ¼‘ºŒ[‰î, ¡ˆä—T, ”’Α׎O
‘O—§‘B‚ª‚ñ‚ÌRhoB”Œ»—U“±[×–E¶•¨Šw“IˆÓ‹`‚Æ—Õ°•a—
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.15)
X’J‘ì–ç, ’·“ˆ^‹I, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, “c‘º¹ŒŽ, ‹Ê錤‘¾˜N, •½ì‹v, “càV“Ä, –Ø‘º“¹•v, “n•Ó‚Ý‚©
“û‘B”S‰t᎗lŽîᇂ̗հ•a—Šw“IŒŸ“¢
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.15)
’†–ì’q—T, ƒMƒƒƒŠEƒcƒF, ƒvƒA[ƒCEƒtƒ“Eƒ^ƒ“, ¬’Ë—SŽi, ŽŒÒ’¼Ž÷, Γc˜a”V, “n•Ó‚Ý‚©, X’J‘ì–ç
ƒgƒŠƒvƒ‹ƒlƒKƒeƒBƒuŒ^”ñZ«“ûŠÇŠà‚ÉŠÖ‚·‚錟“¢FƒAƒWƒA‚É‚¨‚¯‚é”äŠr
‘æ97‰ñ“ú–{•a—Šw‰ï‘‰ï(‹à‘ò)(2008.5.15)
å”g—SŽq, ”g•”KŽi, ŽR’†Œbˆê, ˆé“cŒ›ˆê, •ìˆê˜Y, ’†‘º’mŽ÷, ¼•õº•F, ¼‘ºŒ[‰î, ¬’Ë—SŽi, …’Jm
‘½”«”牺ŽîáŽ‚ð’æ‚µAmalignant rhabdoid tumor‚ƈ««•FŽî‚ÌŠÓ•Ê‚ð—v‚µ‚½ˆê—á
‘æ107‰ñ“ú–{”畆‰ÈŠw‰ï‘‰ï(‹ž“s)(2008.4.19)
]“ª’¼l, ‹Ê“c•×, ŽR‰º•‘¥, ŽR–{—º, ‘]ªÆŠì, ˆÉ“ŒŽ”\, ’r“c‰ë•F, X’J‘ì–ç
“û‘BŽîᇂ̊gŽU‹’²‰æ‘œ@—Lj««•a•ÏAZ/”ñZ•a•ÏA‘gDŒ^‚Ì”äŠr
“ú–{ˆãŠw•úŽËüŠw‰ïŠwpW‰ï(‰¡•l)(2008.4.13)
Š™“c—I, ´…ŒbŽq, ¬–¸¹Žq, ]–Ø‚³‚‚«, ‚ˆÀËŽq, ‘¥¼—Ç–¾, ‘å–ì‰pŽ¡, ÷ˆäF‹K, X’J‘ì–ç, ¬’J‘׈ê
“à–Œ×–Ef‚É‚ÄEndometrial glandular and stromal breakdown‚Æ‚µ‚½Ç—á‚ÌŒŸ“¢
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äj(2007.12.1)
‹TƒZƒcŽq, ²“¡ŽOŽ}Žq, –q–ì_[, ¬àVM‹`, ˆê”——æ, X’J‘ì–ç, –ãà
Žq‹{‘Ì•”‚Ìcondylomatous carcinoma‚Æf’f‚³‚ꂽˆê—á
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äj(2007.12.1)
–{ŠÔ‘¥”V, ’†–ì—LŽq, …–³£V, ²“¡¹–¾, X’J‘ì–ç
’j«‚É”¶‚µ‚½”ñZ«“ûŠÇŠà‚̈ê—á
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äj(2007.12.1)
‰HŒ´—˜K, X’J‘ì–ç, ŽO‰YOŽç, X’J‹±Žq, “¡‘º‹Is, ‰€•”G, ¬’rGŽ¢
Collagenous stroma‚𔺂¤”½‰ž«’†”ç×–E‚ª‘½”oŒ»‚µf’f‚ɋꗶ‚µ‚½• …×–Ef‚̈ê—á
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äj(2007.12.1)
•Ä“c‘€, ¬’Ë—SŽi, ¡ˆä—T, ‰F“cˆŸŠóŽq, –kŽR”ü‰À, “à“cŽ“T, ”’Α׎O
’´‰¹”g“àŽ‹‹¾‰ºúŽh×–Ef(Diff-Quik)‚ª—L—p‚Å‚ ‚Á‚½\“ñŽw’°ƒJƒ‹ƒ`ƒmƒCƒh‚̈ê—á
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äj(2007.12.1)
ŽR‘º–¾Š°, ŽO‰YN, ‘O“cW•½, ‘åÀ”E, ’·”ö@‹I, ¬ŽR~, Ž‹½¹”V, ¬—ÑÆ’‰, ¬ìm, •Ÿ“‡_•½, MŽR—TŽm, ŠC–ì—Ï–¾, ²X–ØŠÞ, X’J‘ì–ç
‘å’°ˆŸ‘S“EŒããè–åŽüˆÍ”^ᇂðŒ_‹@‚É”Œ©‚³‚ꂽFAP‡•¹’¼’°Šà‚̈ê—á
‘æ69‰ñ“ú–{—Õ°ŠO‰ÈŠw‰ï‘‰ïi‰¡•lji2007.11.30j
ŽO‰YOŽç, “n•Ó‚Ý‚©, ˆÀ’B—F’Ã, “c‘º¹ŒŽ, ÎìŒb, ˆÀ“c“Þ’ÃŽq, ù–ìŒöL, X’J‘ì–ç
×–Ef‚͂ǂ±‚܂Œ†”çŽî‚É”—‚ê‚é‚© ×–Ef‚ň««’†”çŽî‚ð„’è‚·‚é@×–EŒ`‘Ô‚©‚ç‚Ý‚½”½‰ž«’†”炨‚æ‚Ñ”x‘BŠà‚Ƃ̊ӕÊ
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äji2007.11.30j
‘¥¼—Ç–¾, ‹yì—mŒb, ‹g“cŽuŽq, ´…ŒbŽq, –î”[Œ¤“ñ, ÷ˆäF‹K, X’J‘ì–ç
Žq‹{“à–Œ×–Ef‚̸“xŒüã‚ð–ÚŽw‚µ‚Ä ƒzƒ‹ƒ‚ƒ“ŠÂ‹«ˆÙí‚É‚¨‚¯‚éŽq‹{“à–Œ‚Ì×–E‘œ
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äji2007.11.30j
’·“ˆ^‹I, H•ÛM•F, “càV“Ä, •½ì‹v, –Ø‘º“¹•v, “c‘º–]ŒŽ, ŽO‰YOŽç, “n•Ó‚Ý‚©, X’J‘ì–ç
”S‰t᎗lŽîá‡(Mucocele-like tumor:MLT)‚Ì×–EŠw“IŒŸ“¢
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äji2007.11.30j
ˆÀ’B—F’Ã, ŽO‰YOŽç, “n•Ó‚Ý‚©, ˆÀ“c“Þ’ÃŽq, ÎìŒb, “c‘º¹ŒŽ, ù–ìŒöL, X’J‘ì–ç
“û“ªót×–EŠà‚Ì×–E‘œ‚ɂ‚¢‚Ä@’W–¾×–EŠà‚Ƃ̔äŠr‚ðŠÜ‚ß‚Ä
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äji2007.11.30j
ÎìŒb, ŽO‰YOŽç, “n•Ó‚Ý‚©, ˆÀ“c“Þ’ÃŽq, “c‘º–]ŒŽ, ˆÀ’B—F’Ã, ŽR‰ºTˆê, ˆÉ“¡–¾G, ù–ìŒöL, X’J‘ì–ç
äNã÷”A˜Hã”çŠàplasmacytoid variant‚̈ê—á
‘æ46‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïiå‘äji2007.11.30j
”öè‘, Š}“‡—¢”ü, ‘S—z, 쓇“ÄO, X’J‘ì–ç, –©G
“û‘BŠOPaget•a‚É‚¨‚¯‚éƒzƒ‹ƒ‚ƒ“ŠÂ‹«‚ɂ‚¢‚Ä
‘æ54‰ñ“ú–{—Õ°ŒŸ¸ˆãŠw‰ïŠwpW‰ïE‘æ47‰ñ“ú–{—Õ°‰»Šw‰ï”NŽŸŠwpW‰ï˜A‡‘å‰ïi‘åãji2007.11.24)
g—Ñ~ˆê, X’J‘ì–ç, ΓcFé, •½ì‹v
ŠàŽ¡—Â̌•ʉ»‚Æ•ªŽqƒ}[ƒJ[(“û‘B) “ûŠà‚ÌIntrinsic subtype•ª—Þ@“ú–{l“ûŠà‚Ì—\Œã‚ª—ÇD‚ÈŒ´ˆö‚Ì’Ç‹†
‘æ45‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ïi‹ž“sj(2007.10.26)
—é–Ø^•F, ŒN“‡ˆÉ‘¢, X‰i^Žj, “n•Ó‹v”üŽq, X’J‘ì–ç
“ûŠà‚ɑ΂·‚ép‘Oƒzƒ‹ƒ‚ƒ“—Ö@‚Ì“K‰ž‚Æ–â‘è“_ ‹ÇЧŒä‚ð–Ú“I‚Æ‚µ‚½p‘Oƒzƒ‹ƒ‚ƒ“—Ö@‚ÌŒŸ“¢
‘æ45‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ïi‹ž“sj(2007.10.26)
ŸNˆä—V, •“cŒ³”Ž, ‘pä»™Ö, ¬—Ñ–F’j, ””’JŒú¶, ŠÃ—˜³˜a, —é–Øº•F, ΓcFé, X’J‘ì–ç, ‘å“àŒ›–¾
V‹KƒˆƒE‰»‹âƒr[ƒY‚̶‘Ì“àŽîᇕª•z‚ɂ‚¢‚Ă̌Ÿ“¢(In vivo distribution of Silver iodide beads in cancerous legions)
‘æ66‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.10.4j
Γc»Œº, ]ìVˆê, Œ³ˆä“~•F, •ŸŽR®Ž¡, —ÍŽR•qŽ÷, •Њñ—F, X’J‘ì–ç, ŒÃì“O, ŠC–ì—Ï–¾
äXindeterminate mucin-producing cystic neoplasm‚Æl‚¦‚ç‚ꂽ”S‰tŽY¶äXŽîᇂÌ2—á
‘æ62‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ïi“Œ‹žji2007.7.19j
‰¡ŽR’q, Œ³ˆä“~•F, •ŸŽR®Ž¡, —ÍŽR•qŽ÷, •Њñ—F, ]ìVˆê, X’J‘ì–ç, ŠC–ì—Ï–¾
\“ñŽw’°ŠàˆÙŽž«—¼‘¤—‘‘ƒ“]ˆÚ‚Ì1—á
‘æ62‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ïi“Œ‹žji2007.7.18j
’·‘º‹`”VC”~‘º‚µ‚Ì‚ÔCX’J‘ì–çCHŽR‘¾
•a—ƒR[ƒi[ƒŒƒNƒ`ƒƒ[
HER2ŒŸ¸E‚¨‚³‚¦‚Ä‚¨‚«‚½‚¢“û‘B޾г‚Ì‘gD‘œ
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.30j
X’J‘ì–çC
•½ì‹vCΓcFéC–Ø‘º“¹•vC“càV“ÄCŒN“‡ˆÉ‘¢C‹g“c´C—é–Ø^•FC‘å“àŒ›–¾Cù–ìŒöL
Šî’ê×–EŒ^“ûŠà‚ÉŠÖ‚·‚é—Õ°•a—Šw“IŒŸ“¢
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.30)
•½ì‹vC“càV“ÄC–Ø‘º“¹•vCˆ¢•Û¹Ž÷CŽÀ•ûˆê“TCX’J‘ì–ç
•¡”‚̃Aƒƒ}ƒ^[ƒ[‘jŠQ܂ɑϫ‚ƂȂÁ‚½isEÄ”“ûŠà‚ɑ΂·‚éCRƒGƒXƒgƒƒQƒ“ܓЗ^Ç—á‚ÌŒŸ“¢
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.30j
X’J‘ì–ç
Rapporteur Session@•a—1-4E—\ŒãˆöŽq1-3
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
g—Ñ~ˆêCHŽR‘¾C–؉ºŠÑ”VC•Z¹ŽjC•ˆäаKCX’J‘ì–ç
“ú–{“ûŠàŠw‰ï“Á•ʑۃvƒƒWƒFƒNƒg”ÇŒ¤‹†•ñ
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
‘åŠÑK“ñC‰““¡“oŠìŽqC‘å“àŒ›–¾CX’J‘ì–çCŒõŽR¹Žì
ƒfƒWƒ^ƒ‹ƒ}ƒ“ƒ‚ƒOƒ‰ƒtƒB‚ƃAƒiƒƒOƒ}ƒ“ƒ‚ƒOƒ‰ƒtƒB‚Ì‘å‹K–Í”äŠr“ljeŽÀŒ±
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
[’¬‰À¢ŽqCΓcFéC•“cŒ³”ŽCŠÃ—˜³˜aC—é–Øº•FC‰F²”üLCŸNˆä—VC“n•”„C‘å“àŒ›–¾CX’J‘ì–ç
“û–[‰·‘¶Žèp‚É‚¨‚¯‚ép’†v‘¬•a—f’f—‘SŽü«’f’[ŒŸõ‚Ì—L—p«
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
Έ䕑ŽqC’|‰Ô‹³C—é–Ø—´Ž™C‰““¡‹`—mC–k‘º“¹•FCX’J‘ì–ç
”äŠr“I¬Œ^‚ÌŽîᎂƂµ‚Ä”Œ©‚³‚ꂽˆ««—tóŽîᇂ̈ê—á
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
“càV“ÄC•½ì‹vC–Ø‘º“¹•vCX’J‘ì–çCˆ¢•Û¹Ž÷CŽÀ•ûˆê“T
ˆ««—tóŽîᇂ̈ê—á
‘æ15‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïi‰¡•lji2007.6.29j
—é–Ø‹M, ŽO–ØNG, X’J‘ì–ç, Ô•½ƒˆê, ΓcFé, ŽRŒû‚ä‚è, —ÑTˆê, ù–ìŒöL
ƒqƒg“ûŠà‚É‚¨‚¯‚éEGR3(early growth response 3)‚Ì”Œ»ˆÓ‹`
‘æ80‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ïi“Œ‹žji2007.6.15j
Ô•½ƒˆê, —é–Ø‹M, —é–ØŽj•F, ŽO‰YˆÉ‹v”ü, ŽO–ØNG, ’·èCŽ¡, Š›ì—R‹IŽq, ˆÉ“¡Œ‰, X’J‘ì–ç, —ÑTˆê, ”ªdŠ~L¶, ù–ìŒöL
ƒqƒgã”ç«—‘‘ƒŠà‚É‚¨‚¯‚éEstrogen receptor-related receptor(ERR)β‚Ì”Œ»‚Æ—Õ°•a—Šw“IˆöŽq‚Ƃ̊֘A‚ɂ‚¢‚Ä
‘æ80‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ïi“Œ‹žji2007.6.14j
´…ŒbŽq, ‘¥¼—Ç–¾, ¬—Ñ’‰’j, ¬–¸¹Žq, ]–Ø‚³‚‚«, ÷ˆäF‹K, X’J‘ì–ç, ‘å–ì‰pŽ¡, ÷ˆäвŒÈ
“û“ªó‰»¶(×–EŽ¿•ω»)‚ª“à–Œ×–Ef¬Ñ‚É‹y‚Ú‚·‰e‹¿
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïiç—tj(2007.6.9)
X’J‘ì–ç, “n•Ó‚Ý‚©, ŽO‰YOŽç, “c‘º¹ŒŽ, ÎìŒb, ˆÀ’B—F’Ã, ù–ìŒöL
“û‘B×–Ef‚̃KƒCƒhƒ‰ƒCƒ“@\‘¢ˆÙŒ^‚Ì–Ê‚©‚ç
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïiç—tj(2007.6.8)
¡–ì—Ç, Šâ¬Ž¡, ’ËŒ´MŒÜ, —é–ØŒõ–¾, ‘å˜a“c—ÏF, Ž™‹ÊÈ“ñ, ¼“c³l, X’J‘ì–ç,
”ÑŒ´‹vmŽq, ŽOã–FŠì, “¡ˆä‘½‹v–, ’·’Jìšæ•F
Žq‹{èòŠàŒŸfƒVƒXƒeƒ€‚É‚¨‚¯‚éHPV-DNAŒŸ¸‚Ì–ðŠ„ Žq‹{èòŠàˆêŽŸƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚¯‚éHPV-DNAƒeƒXƒg‚Æ×–Ef•¹—p‚Ìf’f¸“x
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïiç—tj(2007.6.8)
‘¥¼—Ç–¾, ‹yì—mŒb, ‹g“cŽuŽq, ´…ŒbŽq, –î”[Œ¤“ñ, X’J‘ì–ç
Žq‹{“à–Œ‘BÇ‚ð×–Ef‚łǂ±‚Ü‚Åf’f‚Å‚«‚é‚© Žq‹{“à–Œ‘BÇ‚ð×–Ef‚łǂ±‚Ü‚Åf’f‚Å‚«‚é‚©?
‘æ48‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ïiç—tj(2007.6.8)
Moriya T
Breast Pathology Slide Seminar
5th Asia Pacific International Academy of Pathology Congress, SINGAPORE (2007.5.29)
˜a“cŠî, Έä’q_, ¼Œ÷‘¾˜Y, •—ŠÔ—˜Y, 쌴‹`“T, ²“¡’qs, ²X–؉p”V, “V]V‘¾˜Y, ²–ìMs, ‹g“c–ΕF, ’†‘º, m”ö³‹L, Γc˜a”V, X’J‘ì–ç, •HÀ—²‘¥, Œã“¡‡ˆê, ‰Á“¡—F˜N, —¢Œ©i, —Ñ•x
¶‘Ì•”•ª¬’°ˆÚA‚ðŽ{s‚µ‚½2—á
‘æ107‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ïi‘åãji2007.4.13j
‰F²”üL, X’J‘ì–ç, ΓcFé, •“cŒ³”Ž, ŠÃ—˜³˜a, —é–Øº•F, •½ì‹v, –Ø‘º“¹•v, ŒN“‡ˆÉ‘¢, ù–ìŒöL, ‘å“àŒ›–¾
“ûŠà‚ÌƒŠƒ“ƒpß“]ˆÚ‚ÍZŒa‰½mm‚©‚ç¶‚¸‚é‚©?
‘æ107‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ïi‘åãji2007.4.13)
ìŒûŒj, ]ìVˆê, ‰¡ŽR’q, –؋, Γc»Œº, â“c’¼º, ŽOãK•v, Œ³ˆä“~•F, •ŸŽR®Ž¡, X’J‘ì–ç, ŒÃì“O,ŠC–ì—Ï–¾
äXŠÇ“à“û“ª”S‰t«ŽîᇂÌsubtype‚Æ’ÊíŒ^äXŠàA‘¼‘ŸŠíˆ««Žîᇇ•¹‚Ì‘ŠŠÖ
‘æ107‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ïi‘åãji2007.4.11)
‰ª‘º‰À¢Žq, ΓcFé, •“cŒ³”Ž, ŠÃ—˜³˜a, —é–Øº•F, ”’ÎçŽq, ¬ŒFŒõŒb, ‘½“cа, ‰F²”üL, ˆÉ“¡³—T, ¬‹{—T•¶, ‹g“c‚«‚ÜŽq, X’J‘ì–ç
“û–[‰·‘¶p‚É‚¨‚¢‚Äp’†v‘¬•a—f’f‚Í—L—p‚©?(‘SŽü«’f’[ŒŸõ100—á‚ÌŒŸ“¢)
‘æ107‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ïi‘åãji2007.4.11)
X’J‹±Žq, –öˆäL”V, “¡‘º‹Is, ‰HŒ´—˜K, ‹ù“c‚ ‚¯‚Ý, ‘åX¹Žq, Žs‘º_ˆê, X’J‘ì–ç, ‚‹´¹”V,Ô–Ø’‰Œú
“–‰@‚É‚¨‚¯‚éƒeƒŒƒpƒ\ƒƒW[‚ÌŒ»ó
‘æ24‰ñL“‡Œ§ˆãŠwŒŸ¸Šw‰ïiŒàji2007.3.18)
–xˆä—ŠG, HŽR‘¾, ”~‘º‚µ‚Ì‚Ô, •Z¹Žj, ŠÖ–M•F, –{ŠÔŒcˆê, X’J‘ì–ç, –L“‡—¢Žu, ’Óc‹Ï, –öàVº•v
“û–[‰·‘¶Ž¡—ÃŒã‚̉·‘¶“û–[“àŠà‚Ì•a‘Ô
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.15)
ˆÉ“¡‚µ‚°‚Ý, •Ûâ’qŽq, X’J‘ì–ç, “n•Ó‚Ý‚©, ù–ìŒöL
––½Œ^”xŠà‚É‚¨‚¯‚éŠÔŽ¿‚Ì–¬ŠÇ–§“x‚ÉŠÖ‚·‚錤‹†
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.15)
X’J‘ì–ç
‘Šú“û–[•a•ς̊ӕÊf’f(The differential diagnosis of early breast lesions)
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj (2007.3.14)
X’J‘ì–ç
“ûŠà‚ÌŠÓ•Êf’f‚É‚¨‚¯‚é–Æ‰u‘gDõF‚Ì—L—p«—ŋ߂̘b‘è‚ðŠÜ‚ß‚Ä[
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj (2007.3.14)
’–ŽRŒ«ˆê, –{“c—R”ü, •£Œ°, X’J‘ì–ç, ˆê”——æ, ‘åé^—Žq
æ’[ˆãŠw@ˆã—ÂÌî•ñ‰»‚Æ•a—Šw uP to PŽx‰‡ƒ\ƒtƒgv‚É‚æ‚éƒeƒŒƒpƒ\ƒƒW[Eƒlƒbƒgƒ[ƒN‚Ì\’z‚Æ’nˆæˆã—Âւ̗L—p«
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.14)
‘å“¡‚Žu, X’J‘ì–ç, ŽO‹´’qŽq, Žá‹·Ž¡‹B
‰ñ’°úE‚Å”»–¾‚µ‚½’´‚—îŽÒ‚̬’°ƒNƒ[ƒ“•a‚Ƭ’°ƒzƒWƒLƒ“•a‚̇•¹—á
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.14)
Lì‰ÀŽj, “à“cŽ“T, ¬’Ë—SŽi, ŽR’†Œõ‹K˜N, ‚‘ºŒõK, ¼‘ºŒ[‰î, ¡ˆä—T, “n•Ó¹r, ”’Α׎O
‘O—§‘B‚ª‚ñ×–EPC3‚̃TƒuƒNƒ[ƒ“AM1‚Íã”ç-ŠÔ—t•ÏŠ·‚Å‚ ‚é‚©
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.14)
“à“cŽ“T, ‚‘ºŒõK, ¼‘ºŒ[‰î, ¬’Ë—SŽi, ŽR’†Œõ‹K˜N, ¡ˆä—T, Lì‰ÀŽj, ”’Α׎O
‘O—§‘B”¶‚É‚¨‚¯‚éproprotein convertase‚Ì–ðŠ„
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.14)
X’J‘ì–ç, “n•Ó‚Ý‚©, —é–Ø’¼ŽÀ, •ž•”‡Žq, ²‹vŠÔ“¹Žq, ˆÉ“¡Œ‰, ”ªdŠ~L¶, ù–ìŒöL
Žq‹{“à–Œ‚Æ—‘‘ƒ‚É“¯Žž‚ÉŠà‚ð—L‚·‚éÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.13)
¬’Ë—SŽi, ¡ˆä—T, “à“cŽ“T, ‚‘ºŒõK, ¼‘ºŒ[‰î, Lì‰ÀŽj, ”’Α׎O
Žq‹{èò•”Œ´”Perivascular epithelioid cell tumor(PEComa)‚̈ê—á
‘æ96‰ñ“ú–{•a—Šw‰ï‘‰ïi‘åãj(2007.3.13)
“càV“Ä, •½ì‹v, ˆ¢•Û¹Ž÷, ŽÀ•ûˆê“T, –Ø‘º“¹•v, X’J‘ì–ç
Systemic chemotherapy’†‚ɋNJƒRƒ“ƒgƒ[ƒ‹–Ú“I‚ÅŽèp‚ðŽ{s‚µ‚½25Ç—á‚ÌŒŸ“¢
‘æ4‰ñ“ú–{“ûŠàŠw‰ï“Œ–k’n•û‰ïiå‘äj(2007.3.3)